DNAPK
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| O43918 | S156 | EPSD|PSP | AIRE APECED | EEARAAAPAALTPRGTASPGsQLKAKPPKKPESSAEQQRLP |
| O43918 | T68 | EPSD|PSP | AIRE APECED | HLKEKEGCPQAFHALLSWLLtQDSTAILDFWRVLFKDYNLE |
| O96017 | T383 | EPSD|PSP | CHEK2 CDS1 CHK2 RAD53 | LIKITDFGHsKILGEtsLMRtLCGtPtyLAPEVLVSVGTAG |
| O96017 | T387 | EPSD|PSP | CHEK2 CDS1 CHK2 RAD53 | TDFGHsKILGEtsLMRtLCGtPtyLAPEVLVSVGTAGYNRA |
| O96017 | T68 | SIGNOR|EPSD|PSP | CHEK2 CDS1 CHK2 RAD53 | NSsQSSHSSSGTLSsLETVStQELYsIPEDQEPEDQEPEEP |
| P04150 | S508 | GPS6|SIGNOR|ELM|EPSD | NR3C1 GRL | LEARKTKKKIKGIQQATTGVsQETSENPGNKtIVPAtLPQL |
| P04637 | S15 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | TP53 P53 | ______MEEPQsDPsVEPPLsQEtFsDLWKLLPENNVLsPL |
| P04637 | S20 | iPTMNet|EPSD|PSP | TP53 P53 | _MEEPQsDPsVEPPLsQEtFsDLWKLLPENNVLsPLPsQAM |
| P04637 | S33 | iPTMNet|EPSD | TP53 P53 | PLsQEtFsDLWKLLPENNVLsPLPsQAMDDLMLsPDDIEQW |
| P04637 | S37 | GPS6|ELM|iPTMNet|EPSD|PSP | TP53 P53 | EtFsDLWKLLPENNVLsPLPsQAMDDLMLsPDDIEQWFtED |
| P04637 | S46 | EPSD|PSP | TP53 P53 | LPENNVLsPLPsQAMDDLMLsPDDIEQWFtEDPGPDEAPRM |
| P04637 | S9 | EPSD|PSP | TP53 P53 | ____________MEEPQsDPsVEPPLsQEtFsDLWKLLPEN |
| P04637 | T18 | iPTMNet|EPSD|PSP | TP53 P53 | ___MEEPQsDPsVEPPLsQEtFsDLWKLLPENNVLsPLPsQ |
| P05412 | S249 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | JUN | PQtVPEMPGEtPPLsPIDMEsQERIKAERKRMRNRIAASKC |
| P07900 | T5 | GPS6|SIGNOR|EPSD|PSP | HSP90AA1 HSP90A HSPC1 HSPCA | ________________MPEEtQtQDQPMEEEEVETFAFQAE |
| P07900 | T7 | GPS6|SIGNOR|ELM|EPSD|PSP | HSP90AA1 HSP90A HSPC1 HSPCA | ______________MPEEtQtQDQPMEEEEVETFAFQAEIA |
| P07954 | T236 | SIGNOR|EPSD|PSP | FH | DALDAKSKEFAQIIKIGRTHtQDAVPLTLGQEFSGYVQQVK |
| P08670 | S430 | EPSD|PSP | VIM | RIsLPLPNFssLNLREtNLDsLPLVDtHsKRTLLIKtVEtR |
| P08670 | S459 | EPSD|PSP | VIM | KRTLLIKtVEtRDGQVINEtsQHHDDLE_____________ |
| P08670 | S56 | EPSD|PSP | VIM | RtYsLGsALRPstsRsLyAssPGGVyAtRssAVRLRssVPG |
| P09874 | T594 | PSP | PARP1 ADPRT PPOL | LLEDDKENRYWIFRSWGRVGtVIGSNKLEQMPSKEDAIEHF |
| P11387 | S10 | SIGNOR|EPSD|PSP | TOP1 | ___________MsGDHLHNDsQIEADFRLNDsHKHKDKHKD |
| P11831 | S435 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | SRF | VMYAPTSGLGDGSLTVLNAFsQAPSTMQVSHsQVQEPGGVP |
| P11831 | S446 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | SRF | GSLTVLNAFsQAPSTMQVSHsQVQEPGGVPQVFLTASSGTV |
| P12956 | S27 | SIGNOR|EPSD|PSP | XRCC6 G22P1 | YYKtEGDEEAEEEQEENLEAsGDyKYsGRDsLIFLVDASKA |
| P12956 | S33 | SIGNOR|EPSD|PSP | XRCC6 G22P1 | DEEAEEEQEENLEAsGDyKYsGRDsLIFLVDASKAMFEsQS |
| P12956 | S51 | GPS6|EPSD|PSP | XRCC6 G22P1 | KYsGRDsLIFLVDASKAMFEsQSEDELTPFDMSIQCIQSVY |
| P12956 | S6 | GPS6|EPSD|PSP | XRCC6 G22P1 | _______________MsGWEsYYKtEGDEEAEEEQEENLEA |
| P13010 | S577 | GPS6|EPSD|PSP | XRCC5 G22P2 | NHEDGPTAKKLKtEQGGAHFsVssLAEGsVTSVGSVNPAEN |
| P13010 | S580 | GPS6|EPSD|PSP | XRCC5 G22P2 | DGPTAKKLKtEQGGAHFsVssLAEGsVTSVGSVNPAENFRV |
| P13010 | T715 | EPSD|PSP | XRCC5 G22P2 | sVtAEEAKKFLAPKDKPsGDtAAVFEEGGDVDDLLDMI___ |
| P14859 | S141 | EPSD|PSP | POU2F1 OCT1 OTF1 | LLLQQAQAQAQLLAAAVQQHsAsQQHsAAGATISASAATPM |
| P14859 | S143 | EPSD|PSP | POU2F1 OCT1 OTF1 | LQQAQAQAQLLAAAVQQHsAsQQHsAAGATISASAATPMtQ |
| P14859 | S147 | EPSD|PSP | POU2F1 OCT1 OTF1 | QAQAQLLAAAVQQHsAsQQHsAAGATISASAATPMtQIPLs |
| P14859 | S167 | EPSD|PSP | POU2F1 OCT1 OTF1 | sAAGATISASAATPMtQIPLsQPIQIAQDLQQLQQLQQQNL |
| P14859 | S232 | SIGNOR|EPSD|PSP | POU2F1 OCT1 OTF1 | PQGQQGLLQAQNLLtQLPQQsQANLLQSQPSITLTSQPATP |
| P14859 | S78 | EPSD|PSP | POU2F1 OCT1 OTF1 | GTSLQAAAQSLNVQSKSNEEsGDsQQPsQPsQQPsVQAAIP |
| P14859 | S81 | EPSD|PSP | POU2F1 OCT1 OTF1 | LQAAAQSLNVQSKSNEEsGDsQQPsQPsQQPsVQAAIPQtQ |
| P14859 | S85 | EPSD|PSP | POU2F1 OCT1 OTF1 | AQSLNVQSKSNEEsGDsQQPsQPsQQPsVQAAIPQtQLMLA |
| P14859 | S88 | EPSD|PSP | POU2F1 OCT1 OTF1 | LNVQSKSNEEsGDsQQPsQPsQQPsVQAAIPQtQLMLAGGQ |
| P14859 | S92 | EPSD|PSP | POU2F1 OCT1 OTF1 | SKSNEEsGDsQQPsQPsQQPsVQAAIPQtQLMLAGGQITGL |
| P14859 | T100 | EPSD|PSP | POU2F1 OCT1 OTF1 | DsQQPsQPsQQPsVQAAIPQtQLMLAGGQITGLTLTPAQQQ |
| P14859 | T162 | EPSD|PSP | POU2F1 OCT1 OTF1 | AsQQHsAAGATISASAATPMtQIPLsQPIQIAQDLQQLQQL |
| P14859 | T226 | SIGNOR|EPSD|PSP | POU2F1 OCT1 OTF1 | FIISQTPQGQQGLLQAQNLLtQLPQQsQANLLQSQPSITLT |
| P15927 | S11 | SIGNOR|iPTMNet|EPSD | RPA2 REPA2 RPA32 RPA34 | __________MWNsGFEsYGsssYGGAGGYtQsPGGFGsPA |
| P15927 | S12 | SIGNOR|iPTMNet|EPSD | RPA2 REPA2 RPA32 RPA34 | _________MWNsGFEsYGsssYGGAGGYtQsPGGFGsPAP |
| P15927 | S13 | SIGNOR|iPTMNet|EPSD | RPA2 REPA2 RPA32 RPA34 | ________MWNsGFEsYGsssYGGAGGYtQsPGGFGsPAPs |
| P15927 | S23 | EPSD|PSP | RPA2 REPA2 RPA32 RPA34 | NsGFEsYGsssYGGAGGYtQsPGGFGsPAPsQAEKKSRARA |
| P15927 | S29 | EPSD|PSP | RPA2 REPA2 RPA32 RPA34 | YGsssYGGAGGYtQsPGGFGsPAPsQAEKKSRARAQHIVPC |
| P15927 | S33 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | RPA2 REPA2 RPA32 RPA34 | sYGGAGGYtQsPGGFGsPAPsQAEKKSRARAQHIVPCTIsQ |
| P15927 | S4 | iPTMNet|EPSD|PSP | RPA2 REPA2 RPA32 RPA34 | _________________MWNsGFEsYGsssYGGAGGYtQsP |
| P15927 | S8 | iPTMNet|EPSD|PSP | RPA2 REPA2 RPA32 RPA34 | _____________MWNsGFEsYGsssYGGAGGYtQsPGGFG |
| P15927 | T21 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | RPA2 REPA2 RPA32 RPA34 | MWNsGFEsYGsssYGGAGGYtQsPGGFGsPAPsQAEKKSRA |
| P16104 | S140 | GPS6|EPSD | H2AX H2AFX | KtsAtVGPKAPSGGKKAtQAsQEy_________________ |
| P16104 | T137 | EPSD | H2AX H2AFX | LPKKtsAtVGPKAPSGGKKAtQAsQEy______________ |
| P16403 | T146 | SIGNOR|EPSD|PSP | H1-2 H1F2 HIST1H1C | TKPKKPVGAAKKPKKAAGGAtPKKSAKKTPKKAKKPAAAtV |
| P17936 | S183 | EPSD|PSP | IGFBP3 IBP3 | PKFHPLHSKIIIIKKGHAKDsQRYKVDYESQsTDtQNFssE |
| P18146 | S301 | PSP | EGR1 KROX24 ZNF225 | TQQPSLTPLSTIKAFATQSGsQDLKALNTSYQSQLIKPSRM |
| P18887 | S371 | GPS6|EPSD|PSP | XRCC1 | PDWTRDstHLICAFANtPKYsQVLGLGGRIVRKEWVLDCHR |
| P19838 | S20 | EPSD|PSP | NFKB1 | _MAEDDPYLGRPEQMFHLDPsLTHTIFNPEVFQPQMALPTD |
| P21980 | T162 | PSP | TGM2 | WCPADAVYLDSEEERQEYVLtQQGFIYQGSAKFIKNIPWNF |
| P22415 | S262 | EPSD|PSP | USF1 BHLHB11 USF | GILSKACDyIQELRQSNHRLsEELQGLDQLQLDNDVLRQQV |
| P23025 | S173 | iPTMNet|EPSD|PSP | XPA XPAC | CDLEKREPPLKFIVKKNPHHsQWGDMKLYLKLQIVKRSLEV |
| P23025 | S196 | iPTMNet|EPSD|PSP | XPA XPAC | GDMKLYLKLQIVKRSLEVWGsQEALEEAKEVRQENREKMKQ |
| P23508 | S118 | SIGNOR|PSP | MCC | RLQGTTIREEDEySELRsELsQsQHEVNEDSRSMDQDQTSV |
| P23508 | S120 | SIGNOR|PSP | MCC | QGTTIREEDEySELRsELsQsQHEVNEDSRSMDQDQTSVSI |
| P24928 | S1616 | EPSD|PSP | POLR2A POLR2 | TSPAYEPRSPGGYTPQSPSysPtsPsYsPTsPSYSPTSPNY |
| P24928 | S1621 | EPSD|PSP | POLR2A POLR2 | EPRSPGGYTPQSPSysPtsPsYsPTsPSYSPTSPNYSPTSP |
| P31270 | S98 | EPSD|PSP | HOXA11 HOX1I | NLAHCYsAEELVHRDCLQAPsAAGVPGDVLAKSSANVYHHP |
| P31270 | T119 | EPSD|PSP | HOXA11 HOX1I | AAGVPGDVLAKSSANVYHHPtPAVSSNFYSTVGRNGVLPQA |
| P31749 | S473 | GPS6|SIGNOR|EPSD|PSP | AKT1 PKB RAC | DQDDSMECVDSERRPHFPQFsysAsGtA_____________ |
| P31749 | T308 | PSP | AKT1 PKB RAC | IKITDFGLCKEGIKDGAtMKtFCGtPEyLAPEVLEDNDyGR |
| P35637 | S112 | EPSD|PSP | FUS TLS | GQQSSYPGYGQQPAPSSTSGsYGSSsQSSSYGQPQSGSYsQ |
| P35637 | S117 | EPSD|PSP | FUS TLS | YPGYGQQPAPSSTSGsYGSSsQSSSYGQPQSGSYsQQPSYG |
| P35637 | S131 | EPSD|PSP | FUS TLS | GsYGSSsQSSSYGQPQSGSYsQQPSYGGQQQsYGQQQSYNP |
| P35637 | S142 | EPSD|PSP | FUS TLS | YGQPQSGSYsQQPSYGGQQQsYGQQQSYNPPQGYGQQNQYN |
| P35637 | S26 | EPSD|PSP | FUS TLS | YtQQAtQSYGAYPtQPGQGYsQQSsQPYGQQSYSGYsQSTD |
| P35637 | S30 | EPSD|PSP | FUS TLS | AtQSYGAYPtQPGQGYsQQSsQPYGQQSYSGYsQSTDTSGY |
| P35637 | S42 | EPSD|PSP | FUS TLS | GQGYsQQSsQPYGQQSYSGYsQSTDTSGYGQSsYSSYGQsQ |
| P35637 | S54 | EPSD|PSP | FUS TLS | GQQSYSGYsQSTDTSGYGQSsYSSYGQsQNTGYGtQSTPQG |
| P35637 | S61 | EPSD|PSP | FUS TLS | YsQSTDTSGYGQSsYSSYGQsQNTGYGtQSTPQGYGSTGGY |
| P35637 | S84 | EPSD|PSP | FUS TLS | TGYGtQSTPQGYGSTGGYGSsQSsQSSYGQQSSYPGYGQQP |
| P35637 | S87 | EPSD|PSP | FUS TLS | GtQSTPQGYGSTGGYGSsQSsQSSYGQQSSYPGYGQQPAPS |
| P35637 | T11 | EPSD|PSP | FUS TLS | __________MASNDYtQQAtQSYGAYPtQPGQGYsQQSsQ |
| P35637 | T19 | EPSD|PSP | FUS TLS | __MASNDYtQQAtQSYGAYPtQPGQGYsQQSsQPYGQQSYS |
| P35637 | T68 | EPSD|PSP | FUS TLS | SGYGQSsYSSYGQsQNTGYGtQSTPQGYGSTGGYGSsQSsQ |
| P35637 | T7 | EPSD|PSP | FUS TLS | ______________MASNDYtQQAtQSYGAYPtQPGQGYsQ |
| P42575 | S139 | SIGNOR|EPSD|PSP | CASP2 ICH1 NEDD2 | LTTLSGLQHVLPPLSCDYDLsLPFPVCESCPLYKKLRLstD |
| P46527 | S140 | EPSD|PSP | CDKN1B KIP1 p27 | GAPANSEDTHLVDPKTDPsDsQTGLAEQCAGIRKRPAtDDS |
| P48431 | S251 | PSP | SOX2 | GTPGMALGSMGSVVKSEAsssPPVVtSSSHSRAPCQAGDLR |
| P49917 | S668 | SIGNOR | LIG4 | NLtNVNKISNIFEDVEFCVMsGTDsQPKPDLENRIAEFGGY |
| P49917 | S672 | SIGNOR | LIG4 | VNKISNIFEDVEFCVMsGTDsQPKPDLENRIAEFGGYIVQN |
| P49917 | T650 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | LIG4 | AAPKMKKVIGIIEHLKAPNLtNVNKISNIFEDVEFCVMsGT |
| P52945 | T11 | SIGNOR|EPSD|PSP | PDX1 IPF1 STF1 | __________MNGEEQYYAAtQLYKDPCAFQRGPAPEFSAs |
| P54619 | S192 | SIGNOR|PSP | PRKAG1 | ILKFLKLFITEFPKPEFMSKsLEELQIGTYANIAMVRTTTP |
| P54619 | T284 | SIGNOR|PSP | PRKAG1 | KALQHRSHYFEGVLKCYLHEtLETIINRLVEAEVHRLVVVD |
| P55072 | S784 | EPSD|PSP | VCP HEL-220 HEL-S-70 | QsRGFGsFRFPsGNQGGAGPsQGsGGGtGGsVYTEDNDDDL |
| P55895 | S365 | EPSD|PSP | RAG2 | FYMLKCAEDDTNEEQTTFTNsQTSTEDPGDSTPFEDSEEFC |
| P67809 | T89 | SIGNOR|PSP | YBX1 NSEP1 YB1 | RNGyGFINRNDtKEDVFVHQtAIKKNNPRKyLRsVGDGEtV |
| P78527 | S2053 | GPS6 | PRKDC HYRC HYRC1 | DSTLSEEMsQFDFSTGVQSYsYSsQDPRPATGRFRRREQRD |
| P78527 | S2056 | GPS6|SIGNOR|ELM|EPSD|PSP | PRKDC HYRC HYRC1 | LSEEMsQFDFSTGVQSYsYSsQDPRPATGRFRRREQRDPTV |
| P78527 | S2612 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | PRKDC HYRC HYRC1 | DSDWRFRSTVLtPMFVEtQAsQGtLQtRtQEGsLSARWPVA |
| P78527 | S2624 | SIGNOR|iPTMNet|EPSD | PRKDC HYRC HYRC1 | PMFVEtQAsQGtLQtRtQEGsLSARWPVAGQIRAtQQQHDF |
| P78527 | S3205 | SIGNOR|iPTMNet|EPSD|PSP | PRKDC HYRC HYRC1 | NRCFFLSKIEEKLtPLPEDNsMNVDQDGDPsDRMEVQEQEE |
| P78527 | T2609 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | PRKDC HYRC HYRC1 | YTIDSDWRFRSTVLtPMFVEtQAsQGtLQtRtQEGsLSARW |
| P78527 | T2620 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | PRKDC HYRC HYRC1 | TVLtPMFVEtQAsQGtLQtRtQEGsLSARWPVAGQIRAtQQ |
| P78527 | T2638 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | PRKDC HYRC HYRC1 | tRtQEGsLSARWPVAGQIRAtQQQHDFtLtQtADGRssFDW |
| P78527 | T2647 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | PRKDC HYRC HYRC1 | ARWPVAGQIRAtQQQHDFtLtQtADGRssFDWLTGsstDPL |
| P78527 | T3950 | SIGNOR|EPSD|PSP | PRKDC HYRC HYRC1 | VAMETGGVIGIDFGHAFGSAtQFLPVPELMPFRLTRQFINL |
| Q00839 | S59 | SIGNOR|EPSD|PSP | HNRNPU C1orf199 HNRPU SAFA U21.1 | QAALDDEEAGGRPAMEPGNGsLDLGGDsAGRSGAGLEQEAA |
| Q01860 | S111 | PSP | POU5F1 OCT3 OCT4 OTF3 | ETsQPEGEAGVGVESNSDGAsPEPCTVtPGAVKLEKEKLEQ |
| Q01860 | S93 | PSP | POU5F1 OCT3 OCT4 OTF3 | MAYCGPQVGVGLVPQGGLETsQPEGEAGVGVESNSDGAsPE |
| Q13426 | S260 | GPS6|EPSD|PSP | XRCC4 | QTDLSGLASAAVSKDDsIIssLDVTDIAPSRKRRQRMQRNL |
| Q13426 | S304 | EPSD|PSP | XRCC4 | PKMAPQENQLQEKENsRPDssLPETSKKEHIsAENMsLEtL |
| Q13426 | S320 | GPS6|EPSD|PSP | XRCC4 | RPDssLPETSKKEHIsAENMsLEtLRNssPEDLFDEI____ |
| Q13426 | S327 | SIGNOR|EPSD|PSP | XRCC4 | ETSKKEHIsAENMsLEtLRNssPEDLFDEI___________ |
| Q13426 | S328 | SIGNOR|EPSD|PSP | XRCC4 | TSKKEHIsAENMsLEtLRNssPEDLFDEI____________ |
| Q14191 | S319 | EPSD|PSP | WRN RECQ3 RECQL2 | IIGSTNIETELRPSNNLNLLsFEDSTTGGVQQKQIREHEVL |
| Q14191 | S440 | SIGNOR|EPSD|PSP | WRN RECQ3 RECQL2 | KSTEHLsPNDNENDTSYVIEsDEDLEMEMLKHLSPNDNEND |
| Q14191 | S467 | SIGNOR|PSP | WRN RECQ3 RECQL2 | EMLKHLSPNDNENDTSYVIEsDEDLEMEMLKsLENLNSGTV |
| Q14653 | T135 | SIGNOR|EPSD|PSP | IRF3 | GDFSQPDTsPDTNGGGSTSDtQEDILDELLGNMVLAPLPDP |
| Q15648 | T1457 | EPSD|PSP | MED1 ARC205 CRSP1 CRSP200 DRIP205 DRIP230 PBP PPARBP PPARGBP RB18A TRAP220 TRIP2 | sGstPKHERGsPsHsKsPAytPQNLDsEsEsGSSIAEKsyQ |
| Q8IZL8 | S1033 | PSP | PELP1 HMX3 MNAR | GtEEERGADTAPTLAPEALPsQGEVEREGEsPAAGPPPQEL |
| Q8TCS8 | S776 | SIGNOR|EPSD|PSP | PNPT1 PNPASE | AtTVVRTLNDRssIVMGEPIsQSSSNsQ_____________ |
| Q96SD1 | S503 | SIGNOR|EPSD|PSP | DCLRE1C ARTEMIS ASCID SCIDA SNM1C | DGDVPQWEVFFKRNDEITDEsLENFPSSTVAGGsQsPKLFS |
| Q96SD1 | S516 | SIGNOR|EPSD|PSP | DCLRE1C ARTEMIS ASCID SCIDA SNM1C | NDEITDEsLENFPSSTVAGGsQsPKLFSDsDGESTHISsQN |
| Q96SD1 | S534 | EPSD|PSP | DCLRE1C ARTEMIS ASCID SCIDA SNM1C | GGsQsPKLFSDsDGESTHISsQNSsQSTHITEQGsQGWDsQ |
| Q96SD1 | S538 | EPSD|PSP | DCLRE1C ARTEMIS ASCID SCIDA SNM1C | sPKLFSDsDGESTHISsQNSsQSTHITEQGsQGWDsQSDTV |
| Q96SD1 | S548 | EPSD|PSP | DCLRE1C ARTEMIS ASCID SCIDA SNM1C | ESTHISsQNSsQSTHITEQGsQGWDsQSDTVLLSSQERNSG |
| Q96SD1 | S553 | EPSD|PSP | DCLRE1C ARTEMIS ASCID SCIDA SNM1C | SsQNSsQSTHITEQGsQGWDsQSDTVLLSSQERNSGDITSL |
| Q96SD1 | S645 | SIGNOR|EPSD|PSP | DCLRE1C ARTEMIS ASCID SCIDA SNM1C | SSETHIPEEKSLLNLSTNADsQsssDFEVPstPEAELPKRE |
| Q96T60 | S114 | GPS6|SIGNOR|PSP | PNKP | YLVNGLHPLTLRWEEtRtPEsQPDtPPGtPLVsQDEKRDAE |
| Q96T60 | S126 | GPS6|SIGNOR|PSP | PNKP | WEEtRtPEsQPDtPPGtPLVsQDEKRDAELPKKRMRKsNPG |
| Q9BPZ7 | S186 | PSP | MAPKAP1 MIP1 SIN1 | KGHVGTTATKKIDVYLPLHssQDRLLPMTVVTMAsARVQDL |
| Q9BPZ7 | S343 | PSP | MAPKAP1 MIP1 SIN1 | YRLEKQSEPNVAVDLDSTLEsQSAWEFCLVRENSSRADGVF |
| Q9BPZ7 | S367 | PSP | MAPKAP1 MIP1 SIN1 | WEFCLVRENSSRADGVFEEDsQIDIATVQDMLSSHHYKSFK |
| Q9BQ15 | S134 | EPSD|PSP | NABP2 OBFC2B SSB1 LP3587 | EYStQQAPNKAVQNDSNPSAsQPTTGPSAASPASENQNGNG |
| Q9H4A6 | T143 | SIGNOR|EPSD|PSP | GOLPH3 GPP34 | KSDAPTGDVLLDEALKHVKEtQPPEtVQNWIELLSGETWNP |
| Q9H4A6 | T148 | SIGNOR|EPSD|PSP | GOLPH3 GPP34 | TGDVLLDEALKHVKEtQPPEtVQNWIELLSGETWNPLKLHY |
| Q9H9Q4 | S132 | EPSD|PSP | NHEJ1 XLF | LSGLPFYWNFHCMLASPSLVsQHLIRPLMGMSLALQCQVRE |
| Q9H9Q4 | S245 | SIGNOR|EPSD|PSP | NHEJ1 XLF | EVQVGQKHQGAGDPHTSNSAsLQGIDsQCVNQPEQLVSsAP |
| Q9H9Q4 | S251 | EPSD|PSP | NHEJ1 XLF | KHQGAGDPHTSNSAsLQGIDsQCVNQPEQLVSsAPtLSAPE |
| Q9H9Q4 | S263 | EPSD|PSP | NHEJ1 XLF | SAsLQGIDsQCVNQPEQLVSsAPtLSAPEKESTGTsGPLQR |
| Q9H9Q4 | S55 | EPSD|PSP | NHEJ1 XLF | ALLVSDLQQVWHEQVDTSVVsQRAKELNKRLTAPPAAFLCH |
| Q9H9Q4 | T223 | EPSD|PSP | NHEJ1 XLF | sIGDGKPFVMNLQDLYMAVTtQEVQVGQKHQGAGDPHTSNS |
| Q9H9Q4 | T266 | EPSD|PSP | NHEJ1 XLF | LQGIDsQCVNQPEQLVSsAPtLSAPEKESTGTsGPLQRPQL |
| Q9NUW8 | S81 | SIGNOR|EPSD|PSP | TDP1 | SPVKFSNTDSVLPPKRQKSGsQEDLGWCLSSSDDELQPEMP |
| Q9UBK2 | S636 | SIGNOR | PPARGC1A LEM6 PGC1 PGC1A PPARGC1 | SPLYVRSRSRSPYSRRPRYDsYEEYQHERLKREEYRREYEK |
| Q9UGP5 | T204 | SIGNOR|EPSD|PSP | POLL | EAPNTQAQPISDDEASDGEEtQVSAADLEALISGHYPTSLE |
| Q9Y294 | S192 | PSP | ASF1A CGI-98 HSPC146 | sLLstDALPsAsKGWSTSENsLNVMLESHMDCM________ |
| Q9Y6K9 | S43 | GPS6|SIGNOR|PSP | IKBKG FIP3 NEMO | DQDVLGEEsPLGKPAMLHLPsEQGAPETLQRCLEENQELRD |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cell Cycle | R-HSA-1640170 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 3.863576e-14 | 13.413 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.830647e-12 | 11.737 | 0 | 0 |
| M Phase | R-HSA-68886 | 3.205313e-10 | 9.494 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 3.780638e-09 | 8.422 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 6.798017e-09 | 8.168 | 1 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.149445e-08 | 7.940 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 1.388371e-08 | 7.857 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 5.064272e-08 | 7.295 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 2.252405e-07 | 6.647 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 2.566801e-07 | 6.591 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 2.783996e-07 | 6.555 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 3.312445e-07 | 6.480 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 4.112024e-07 | 6.386 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 4.140714e-07 | 6.383 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 4.754977e-07 | 6.323 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 5.253186e-07 | 6.280 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 9.315658e-07 | 6.031 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.185156e-06 | 5.926 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 1.352614e-06 | 5.869 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 1.597392e-06 | 5.797 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.778778e-06 | 5.750 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 1.977555e-06 | 5.704 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 2.957714e-06 | 5.529 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 4.099124e-06 | 5.387 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 4.125859e-06 | 5.384 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 6.099855e-06 | 5.215 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 6.099855e-06 | 5.215 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 8.697569e-06 | 5.061 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 9.685541e-06 | 5.014 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 1.047611e-05 | 4.980 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 1.199795e-05 | 4.921 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.325010e-05 | 4.878 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.349250e-05 | 4.870 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 1.475078e-05 | 4.831 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 1.528527e-05 | 4.816 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.544184e-05 | 4.811 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 1.765584e-05 | 4.753 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 1.961259e-05 | 4.707 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 2.200491e-05 | 4.657 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 2.248241e-05 | 4.648 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 2.248241e-05 | 4.648 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 2.201314e-05 | 4.657 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 2.260503e-05 | 4.646 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 2.681463e-05 | 4.572 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 2.884185e-05 | 4.540 | 1 | 1 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 3.056795e-05 | 4.515 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 3.403536e-05 | 4.468 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 3.403536e-05 | 4.468 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 3.403536e-05 | 4.468 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 3.403536e-05 | 4.468 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 3.522920e-05 | 4.453 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 3.602548e-05 | 4.443 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 3.641624e-05 | 4.439 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 3.641624e-05 | 4.439 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 3.657375e-05 | 4.437 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 4.126803e-05 | 4.384 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 4.432888e-05 | 4.353 | 0 | 0 |
| Kinesins | R-HSA-983189 | 5.177218e-05 | 4.286 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 5.566855e-05 | 4.254 | 1 | 1 |
| mRNA Splicing | R-HSA-72172 | 5.541430e-05 | 4.256 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 5.597793e-05 | 4.252 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 5.461958e-05 | 4.263 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 7.679201e-05 | 4.115 | 1 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 8.203052e-05 | 4.086 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 8.299073e-05 | 4.081 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 9.240565e-05 | 4.034 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 9.240565e-05 | 4.034 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 8.867213e-05 | 4.052 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 9.205528e-05 | 4.036 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 9.309688e-05 | 4.031 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 9.309688e-05 | 4.031 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 9.435966e-05 | 4.025 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 1.181215e-04 | 3.928 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 1.332148e-04 | 3.875 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 1.422848e-04 | 3.847 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 1.457015e-04 | 3.837 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 1.570994e-04 | 3.804 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 1.716992e-04 | 3.765 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 1.680418e-04 | 3.775 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.728404e-04 | 3.762 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.736358e-04 | 3.760 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 1.786504e-04 | 3.748 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 1.833911e-04 | 3.737 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 1.925578e-04 | 3.715 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 1.925578e-04 | 3.715 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 2.006416e-04 | 3.698 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 2.099870e-04 | 3.678 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 2.141192e-04 | 3.669 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 2.305794e-04 | 3.637 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 2.643834e-04 | 3.578 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 2.637640e-04 | 3.579 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 2.514255e-04 | 3.600 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 2.593943e-04 | 3.586 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 2.593943e-04 | 3.586 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 2.510282e-04 | 3.600 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 2.409177e-04 | 3.618 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 2.632739e-04 | 3.580 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 2.741123e-04 | 3.562 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 3.001453e-04 | 3.523 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 3.036978e-04 | 3.518 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 3.077509e-04 | 3.512 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 3.408318e-04 | 3.467 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 3.961134e-04 | 3.402 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 4.195898e-04 | 3.377 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 4.431714e-04 | 3.353 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 4.462986e-04 | 3.350 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 4.708572e-04 | 3.327 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 4.755398e-04 | 3.323 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 5.785945e-04 | 3.238 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 5.785945e-04 | 3.238 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 5.669008e-04 | 3.246 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 5.786506e-04 | 3.238 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 5.789469e-04 | 3.237 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 5.905034e-04 | 3.229 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 6.027693e-04 | 3.220 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 6.047075e-04 | 3.218 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 6.895471e-04 | 3.161 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 6.895471e-04 | 3.161 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 6.895471e-04 | 3.161 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 6.895471e-04 | 3.161 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 6.530320e-04 | 3.185 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 6.817641e-04 | 3.166 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 7.173531e-04 | 3.144 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 7.219131e-04 | 3.142 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 7.946646e-04 | 3.100 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 7.946646e-04 | 3.100 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 7.627952e-04 | 3.118 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 8.016506e-04 | 3.096 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 8.272901e-04 | 3.082 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 8.272901e-04 | 3.082 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 8.354107e-04 | 3.078 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 8.354107e-04 | 3.078 | 0 | 0 |
| S Phase | R-HSA-69242 | 8.437531e-04 | 3.074 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 9.179748e-04 | 3.037 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 9.051808e-04 | 3.043 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 9.051808e-04 | 3.043 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 9.180349e-04 | 3.037 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 9.674861e-04 | 3.014 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 9.674861e-04 | 3.014 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 9.680637e-04 | 3.014 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 9.741341e-04 | 3.011 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 9.825571e-04 | 3.008 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 9.921743e-04 | 3.003 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.093901e-03 | 2.961 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 1.018483e-03 | 2.992 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 1.098362e-03 | 2.959 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 1.116025e-03 | 2.952 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 1.158030e-03 | 2.936 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.169786e-03 | 2.932 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 1.204537e-03 | 2.919 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 1.243927e-03 | 2.905 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 1.244902e-03 | 2.905 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 1.279364e-03 | 2.893 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.295915e-03 | 2.887 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 1.417546e-03 | 2.848 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 1.450189e-03 | 2.839 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 1.450189e-03 | 2.839 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 1.488566e-03 | 2.827 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 1.576292e-03 | 2.802 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 1.669212e-03 | 2.777 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 1.726608e-03 | 2.763 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.770169e-03 | 2.752 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 2.018022e-03 | 2.695 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 1.978429e-03 | 2.704 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 2.147063e-03 | 2.668 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 2.156165e-03 | 2.666 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 2.169785e-03 | 2.664 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 2.169785e-03 | 2.664 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 2.415436e-03 | 2.617 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 2.530672e-03 | 2.597 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 2.620950e-03 | 2.582 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 3.037668e-03 | 2.517 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 2.851938e-03 | 2.545 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 2.763074e-03 | 2.559 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 2.838814e-03 | 2.547 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 2.784959e-03 | 2.555 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 2.803273e-03 | 2.552 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 3.100877e-03 | 2.509 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 3.100877e-03 | 2.509 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 3.116821e-03 | 2.506 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 3.138102e-03 | 2.503 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 3.322847e-03 | 2.478 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 3.476054e-03 | 2.459 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 3.573754e-03 | 2.447 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 3.674357e-03 | 2.435 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 3.713137e-03 | 2.430 | 1 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 3.723563e-03 | 2.429 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 3.726184e-03 | 2.429 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 3.738495e-03 | 2.427 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 3.773628e-03 | 2.423 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 3.976584e-03 | 2.400 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 4.281243e-03 | 2.368 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 4.281243e-03 | 2.368 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 4.457019e-03 | 2.351 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 4.049507e-03 | 2.393 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 4.096163e-03 | 2.388 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 4.601074e-03 | 2.337 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 4.601074e-03 | 2.337 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 4.601074e-03 | 2.337 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 4.096163e-03 | 2.388 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 4.480142e-03 | 2.349 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 4.222064e-03 | 2.374 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 4.069287e-03 | 2.390 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 4.201003e-03 | 2.377 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 4.894163e-03 | 2.310 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 4.905058e-03 | 2.309 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 5.279175e-03 | 2.277 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 5.297871e-03 | 2.276 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 5.522095e-03 | 2.258 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 5.725759e-03 | 2.242 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 5.900808e-03 | 2.229 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 6.614171e-03 | 2.180 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 6.614171e-03 | 2.180 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 6.378173e-03 | 2.195 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 6.378173e-03 | 2.195 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 6.378173e-03 | 2.195 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 6.616098e-03 | 2.179 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 6.616098e-03 | 2.179 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 6.037858e-03 | 2.219 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 6.002143e-03 | 2.222 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 6.889274e-03 | 2.162 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 6.614171e-03 | 2.180 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 6.533125e-03 | 2.185 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 6.084051e-03 | 2.216 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 6.235610e-03 | 2.205 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 6.115468e-03 | 2.214 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 6.037858e-03 | 2.219 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 6.665163e-03 | 2.176 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 6.037858e-03 | 2.219 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 6.616098e-03 | 2.179 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 7.153482e-03 | 2.145 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 7.190386e-03 | 2.143 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 7.190386e-03 | 2.143 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 7.295088e-03 | 2.137 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 7.403947e-03 | 2.131 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 7.434554e-03 | 2.129 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 7.571414e-03 | 2.121 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 7.571414e-03 | 2.121 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 7.740343e-03 | 2.111 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 7.740343e-03 | 2.111 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 7.740343e-03 | 2.111 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 7.740343e-03 | 2.111 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 7.740343e-03 | 2.111 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 7.860420e-03 | 2.105 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 7.898569e-03 | 2.102 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 7.898569e-03 | 2.102 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 8.058112e-03 | 2.094 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 8.419442e-03 | 2.075 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 8.419442e-03 | 2.075 | 1 | 1 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 8.447097e-03 | 2.073 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 8.843403e-03 | 2.053 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 9.289726e-03 | 2.032 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 9.862501e-03 | 2.006 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 1.095495e-02 | 1.960 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 1.118409e-02 | 1.951 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 1.090262e-02 | 1.962 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 9.619718e-03 | 2.017 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 1.077835e-02 | 1.967 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 1.042942e-02 | 1.982 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 1.094683e-02 | 1.961 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 1.152825e-02 | 1.938 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 9.862501e-03 | 2.006 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 1.025275e-02 | 1.989 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 9.734652e-03 | 2.012 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 1.033473e-02 | 1.986 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 1.090262e-02 | 1.962 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 1.179971e-02 | 1.928 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 1.184095e-02 | 1.927 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 1.290448e-02 | 1.889 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 1.297648e-02 | 1.887 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 1.302468e-02 | 1.885 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 1.314454e-02 | 1.881 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 1.325547e-02 | 1.878 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 1.385754e-02 | 1.858 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 1.390287e-02 | 1.857 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 1.411010e-02 | 1.850 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 1.411010e-02 | 1.850 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 1.445455e-02 | 1.840 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 1.453076e-02 | 1.838 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 1.456673e-02 | 1.837 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 1.456673e-02 | 1.837 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 1.478892e-02 | 1.830 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 1.495039e-02 | 1.825 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 1.500489e-02 | 1.824 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.549575e-02 | 1.810 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 1.551851e-02 | 1.809 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 1.561218e-02 | 1.807 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 1.609563e-02 | 1.793 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 1.615894e-02 | 1.792 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 1.644072e-02 | 1.784 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 1.650979e-02 | 1.782 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 1.780604e-02 | 1.749 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 1.780604e-02 | 1.749 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 1.948962e-02 | 1.710 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 1.736638e-02 | 1.760 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 1.857062e-02 | 1.731 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 1.931552e-02 | 1.714 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 1.999982e-02 | 1.699 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 2.004384e-02 | 1.698 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.740452e-02 | 1.759 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 2.092652e-02 | 1.679 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 1.746825e-02 | 1.758 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 2.092652e-02 | 1.679 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 1.949355e-02 | 1.710 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.780855e-02 | 1.749 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 1.948962e-02 | 1.710 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 1.944462e-02 | 1.711 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 1.929914e-02 | 1.714 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 1.948962e-02 | 1.710 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 2.092652e-02 | 1.679 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 2.087218e-02 | 1.680 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 1.740452e-02 | 1.759 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 1.757917e-02 | 1.755 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 2.192939e-02 | 1.659 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 2.192939e-02 | 1.659 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 2.247839e-02 | 1.648 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 2.247839e-02 | 1.648 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 2.255234e-02 | 1.647 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 2.267004e-02 | 1.645 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 2.287587e-02 | 1.641 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 2.346173e-02 | 1.630 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 2.346173e-02 | 1.630 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 2.346173e-02 | 1.630 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 2.349997e-02 | 1.629 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 2.376715e-02 | 1.624 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 2.385981e-02 | 1.622 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 2.491211e-02 | 1.604 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 2.515464e-02 | 1.599 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 2.515464e-02 | 1.599 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 2.515464e-02 | 1.599 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 2.515464e-02 | 1.599 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 2.515464e-02 | 1.599 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 2.547780e-02 | 1.594 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 2.611842e-02 | 1.583 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 2.611842e-02 | 1.583 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 2.611842e-02 | 1.583 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 2.617565e-02 | 1.582 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 2.624720e-02 | 1.581 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 2.624720e-02 | 1.581 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 2.624720e-02 | 1.581 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 2.658868e-02 | 1.575 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 2.705074e-02 | 1.568 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 2.881981e-02 | 1.540 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 2.910156e-02 | 1.536 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 2.910156e-02 | 1.536 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 2.929625e-02 | 1.533 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 2.929625e-02 | 1.533 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 2.931213e-02 | 1.533 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 3.622678e-02 | 1.441 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 3.622678e-02 | 1.441 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 3.622678e-02 | 1.441 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 3.622678e-02 | 1.441 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 3.622678e-02 | 1.441 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 3.622678e-02 | 1.441 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 3.622678e-02 | 1.441 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 3.622678e-02 | 1.441 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 3.622678e-02 | 1.441 | 0 | 0 |
| STAT6-mediated induction of chemokines | R-HSA-3249367 | 3.943691e-02 | 1.404 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 3.943691e-02 | 1.404 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 3.943691e-02 | 1.404 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 3.943691e-02 | 1.404 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 3.264428e-02 | 1.486 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 3.499289e-02 | 1.456 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 3.409473e-02 | 1.467 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 3.409473e-02 | 1.467 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 3.409473e-02 | 1.467 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 3.409473e-02 | 1.467 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 3.409473e-02 | 1.467 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 3.409473e-02 | 1.467 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 3.184830e-02 | 1.497 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 3.173116e-02 | 1.499 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 3.795348e-02 | 1.421 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 3.795348e-02 | 1.421 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 3.338003e-02 | 1.477 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 3.927607e-02 | 1.406 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 3.015270e-02 | 1.521 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 3.015270e-02 | 1.521 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 3.234982e-02 | 1.490 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 3.020916e-02 | 1.520 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 3.635099e-02 | 1.439 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 3.315278e-02 | 1.479 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 3.430305e-02 | 1.465 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 3.959573e-02 | 1.402 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 3.717342e-02 | 1.430 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 3.717342e-02 | 1.430 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 3.059579e-02 | 1.514 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 3.264428e-02 | 1.486 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 3.499289e-02 | 1.456 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 3.499289e-02 | 1.456 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 3.467544e-02 | 1.460 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 2.996149e-02 | 1.523 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 3.467544e-02 | 1.460 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 3.392239e-02 | 1.470 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 3.015270e-02 | 1.521 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 3.468854e-02 | 1.460 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 3.191867e-02 | 1.496 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 3.795348e-02 | 1.421 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 3.264428e-02 | 1.486 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 3.264428e-02 | 1.486 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 3.052412e-02 | 1.515 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 3.430305e-02 | 1.465 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 3.362347e-02 | 1.473 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 3.371990e-02 | 1.472 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 3.264428e-02 | 1.486 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 3.264428e-02 | 1.486 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 3.963896e-02 | 1.402 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 3.963896e-02 | 1.402 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 3.963896e-02 | 1.402 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 4.090040e-02 | 1.388 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 4.204043e-02 | 1.376 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 4.291514e-02 | 1.367 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 4.303834e-02 | 1.366 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 4.303834e-02 | 1.366 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 4.303834e-02 | 1.366 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 4.349480e-02 | 1.362 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 4.349480e-02 | 1.362 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 4.389325e-02 | 1.358 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 4.404028e-02 | 1.356 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 4.602286e-02 | 1.337 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 4.644242e-02 | 1.333 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 4.644242e-02 | 1.333 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 4.644242e-02 | 1.333 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 4.670046e-02 | 1.331 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 4.670046e-02 | 1.331 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 4.742348e-02 | 1.324 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 4.742348e-02 | 1.324 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 4.751006e-02 | 1.323 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 4.772738e-02 | 1.321 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 4.857787e-02 | 1.314 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 4.892058e-02 | 1.311 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 4.908495e-02 | 1.309 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 5.034081e-02 | 1.298 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 5.067502e-02 | 1.295 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 5.087503e-02 | 1.293 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 5.087503e-02 | 1.293 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 5.087503e-02 | 1.293 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 5.141834e-02 | 1.289 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 5.142083e-02 | 1.289 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 5.142083e-02 | 1.289 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 5.277726e-02 | 1.278 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 5.277726e-02 | 1.278 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 5.279987e-02 | 1.277 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 5.279987e-02 | 1.277 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 5.313092e-02 | 1.275 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 5.313092e-02 | 1.275 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 5.359487e-02 | 1.271 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 5.402434e-02 | 1.267 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 5.437115e-02 | 1.265 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 5.437115e-02 | 1.265 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 5.437115e-02 | 1.265 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 5.437115e-02 | 1.265 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 5.495226e-02 | 1.260 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 5.547165e-02 | 1.256 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 5.721924e-02 | 1.242 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 5.775763e-02 | 1.238 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 5.778438e-02 | 1.238 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 5.870198e-02 | 1.231 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 5.870198e-02 | 1.231 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 5.956910e-02 | 1.225 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 5.956910e-02 | 1.225 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 5.987120e-02 | 1.223 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 5.987120e-02 | 1.223 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 6.062758e-02 | 1.217 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 6.113696e-02 | 1.214 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 6.127093e-02 | 1.213 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 6.127093e-02 | 1.213 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 6.127093e-02 | 1.213 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 6.127093e-02 | 1.213 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 6.127093e-02 | 1.213 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 6.127093e-02 | 1.213 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 6.143401e-02 | 1.212 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 6.143401e-02 | 1.212 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 6.160414e-02 | 1.210 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 6.318750e-02 | 1.199 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 6.361636e-02 | 1.196 | 0 | 0 |
| Inhibition of Host mRNA Processing and RNA Silencing | R-HSA-168315 | 7.406795e-02 | 1.130 | 0 | 0 |
| IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) | R-HSA-5603027 | 7.406795e-02 | 1.130 | 0 | 0 |
| IKBKB deficiency causes SCID | R-HSA-5602636 | 7.406795e-02 | 1.130 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 8.756113e-02 | 1.058 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 8.756113e-02 | 1.058 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 8.756113e-02 | 1.058 | 0 | 0 |
| IRS activation | R-HSA-74713 | 8.756113e-02 | 1.058 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 8.756113e-02 | 1.058 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 8.756113e-02 | 1.058 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 8.330634e-02 | 1.079 | 0 | 0 |
| RSK activation | R-HSA-444257 | 8.330634e-02 | 1.079 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 7.527917e-02 | 1.123 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 6.675176e-02 | 1.176 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 6.675176e-02 | 1.176 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 6.675176e-02 | 1.176 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 6.675176e-02 | 1.176 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 9.262456e-02 | 1.033 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 9.262456e-02 | 1.033 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 9.262456e-02 | 1.033 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 9.262456e-02 | 1.033 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 9.262456e-02 | 1.033 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 9.262456e-02 | 1.033 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 9.262456e-02 | 1.033 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 9.262456e-02 | 1.033 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 8.064019e-02 | 1.093 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 9.601642e-02 | 1.018 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 9.601642e-02 | 1.018 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 9.601642e-02 | 1.018 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 8.257855e-02 | 1.083 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 8.254236e-02 | 1.083 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 9.493738e-02 | 1.023 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 8.132419e-02 | 1.090 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 6.633701e-02 | 1.178 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 8.964739e-02 | 1.047 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 7.438839e-02 | 1.128 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 6.880547e-02 | 1.162 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 7.619659e-02 | 1.118 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 7.283869e-02 | 1.138 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 8.408404e-02 | 1.075 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 8.004419e-02 | 1.097 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 8.653267e-02 | 1.063 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 8.653267e-02 | 1.063 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 8.210334e-02 | 1.086 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 8.257855e-02 | 1.083 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 7.527917e-02 | 1.123 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 7.198959e-02 | 1.143 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 8.653267e-02 | 1.063 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 6.633701e-02 | 1.178 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 6.598076e-02 | 1.181 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 8.132419e-02 | 1.090 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 8.964739e-02 | 1.047 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 8.015001e-02 | 1.096 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 8.132419e-02 | 1.090 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 7.067507e-02 | 1.151 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 7.003326e-02 | 1.155 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 8.257855e-02 | 1.083 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 6.988536e-02 | 1.156 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 8.264278e-02 | 1.083 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 8.303958e-02 | 1.081 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 6.988536e-02 | 1.156 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 7.619659e-02 | 1.118 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 8.330634e-02 | 1.079 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 9.601642e-02 | 1.018 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 8.132419e-02 | 1.090 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 8.653267e-02 | 1.063 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 8.964739e-02 | 1.047 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 6.956426e-02 | 1.158 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 6.956426e-02 | 1.158 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 9.318461e-02 | 1.031 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 8.330634e-02 | 1.079 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 7.527917e-02 | 1.123 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 6.829719e-02 | 1.166 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 8.015001e-02 | 1.096 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 8.330634e-02 | 1.079 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 8.330634e-02 | 1.079 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 6.880547e-02 | 1.162 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 9.403667e-02 | 1.027 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 8.064019e-02 | 1.093 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 7.828835e-02 | 1.106 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 6.633701e-02 | 1.178 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 8.330634e-02 | 1.079 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 8.257855e-02 | 1.083 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 9.632969e-02 | 1.016 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 9.632969e-02 | 1.016 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 9.649570e-02 | 1.015 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 9.654517e-02 | 1.015 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 9.722247e-02 | 1.012 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 9.928086e-02 | 1.003 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 1.013632e-01 | 0.994 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 1.013632e-01 | 0.994 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 1.013632e-01 | 0.994 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 1.019404e-01 | 0.992 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 1.021564e-01 | 0.991 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 1.046813e-01 | 0.980 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 1.046813e-01 | 0.980 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 1.046813e-01 | 0.980 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 1.056085e-01 | 0.976 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 1.056085e-01 | 0.976 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 1.056085e-01 | 0.976 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 1.056085e-01 | 0.976 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 1.056085e-01 | 0.976 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.072455e-01 | 0.970 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 1.072455e-01 | 0.970 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 1.072455e-01 | 0.970 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 1.077796e-01 | 0.967 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 1.083324e-01 | 0.965 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 1.083324e-01 | 0.965 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 1.112640e-01 | 0.954 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 1.112640e-01 | 0.954 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 1.118282e-01 | 0.951 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 1.118282e-01 | 0.951 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 1.118282e-01 | 0.951 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 1.118282e-01 | 0.951 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 1.118282e-01 | 0.951 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 1.124381e-01 | 0.949 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 1.124381e-01 | 0.949 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 1.128383e-01 | 0.948 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 1.128383e-01 | 0.948 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 1.128383e-01 | 0.948 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 1.128383e-01 | 0.948 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 1.128383e-01 | 0.948 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 1.128383e-01 | 0.948 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 1.170288e-01 | 0.932 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 1.177392e-01 | 0.929 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 1.177392e-01 | 0.929 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 1.177392e-01 | 0.929 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 1.177392e-01 | 0.929 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 1.177392e-01 | 0.929 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 1.177392e-01 | 0.929 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 1.177392e-01 | 0.929 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 1.186617e-01 | 0.926 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 1.186617e-01 | 0.926 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 1.191336e-01 | 0.924 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 1.198076e-01 | 0.922 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 1.198076e-01 | 0.922 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 1.198076e-01 | 0.922 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 1.198076e-01 | 0.922 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 1.198076e-01 | 0.922 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 1.198076e-01 | 0.922 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 1.198076e-01 | 0.922 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 1.198076e-01 | 0.922 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 1.198076e-01 | 0.922 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 1.198076e-01 | 0.922 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 1.198076e-01 | 0.922 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 1.198076e-01 | 0.922 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 1.198076e-01 | 0.922 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 1.198076e-01 | 0.922 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 1.236828e-01 | 0.908 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 1.245257e-01 | 0.905 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 1.256424e-01 | 0.901 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 1.265301e-01 | 0.898 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 1.265633e-01 | 0.898 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 1.265633e-01 | 0.898 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 1.273452e-01 | 0.895 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 1.303013e-01 | 0.885 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 1.303013e-01 | 0.885 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.303013e-01 | 0.885 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 1.303013e-01 | 0.885 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 1.303013e-01 | 0.885 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 1.310437e-01 | 0.883 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 1.310437e-01 | 0.883 | 0 | 0 |
| PKA activation | R-HSA-163615 | 1.310437e-01 | 0.883 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 1.310437e-01 | 0.883 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 1.310437e-01 | 0.883 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 1.314404e-01 | 0.881 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 1.325443e-01 | 0.878 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 1.327787e-01 | 0.877 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.327787e-01 | 0.877 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 1.336803e-01 | 0.874 | 0 | 0 |
| Drug resistance of PDGFR mutants | R-HSA-9674415 | 1.379346e-01 | 0.860 | 0 | 0 |
| PDGFR mutants bind TKIs | R-HSA-9674428 | 1.379346e-01 | 0.860 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 1.379346e-01 | 0.860 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 1.379346e-01 | 0.860 | 0 | 0 |
| Regorafenib-resistant PDGFR mutants | R-HSA-9674403 | 1.379346e-01 | 0.860 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 1.379346e-01 | 0.860 | 0 | 0 |
| Sorafenib-resistant PDGFR mutants | R-HSA-9674404 | 1.379346e-01 | 0.860 | 0 | 0 |
| Imatinib-resistant PDGFR mutants | R-HSA-9674396 | 1.379346e-01 | 0.860 | 0 | 0 |
| Sunitinib-resistant PDGFR mutants | R-HSA-9674401 | 1.379346e-01 | 0.860 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 1.412235e-01 | 0.850 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 1.417671e-01 | 0.848 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 1.419138e-01 | 0.848 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 1.445244e-01 | 0.840 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 1.460446e-01 | 0.836 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 1.460446e-01 | 0.836 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 1.475590e-01 | 0.831 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 1.488136e-01 | 0.827 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 1.501311e-01 | 0.824 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 1.511605e-01 | 0.821 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 1.511605e-01 | 0.821 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 1.511605e-01 | 0.821 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 1.511605e-01 | 0.821 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 1.511605e-01 | 0.821 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 1.533817e-01 | 0.814 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.553381e-01 | 0.809 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 1.553381e-01 | 0.809 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 1.553381e-01 | 0.809 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 1.571199e-01 | 0.804 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 1.571199e-01 | 0.804 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 1.571199e-01 | 0.804 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 1.571199e-01 | 0.804 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 1.576913e-01 | 0.802 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 1.579057e-01 | 0.802 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 1.614247e-01 | 0.792 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 1.627412e-01 | 0.789 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 1.630526e-01 | 0.788 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 1.650867e-01 | 0.782 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 2.568501e-01 | 0.590 | 0 | 0 |
| Drug-mediated inhibition of MET activation | R-HSA-9734091 | 2.568501e-01 | 0.590 | 0 | 0 |
| Defective Mismatch Repair Associated With PMS2 | R-HSA-5632987 | 2.568501e-01 | 0.590 | 0 | 0 |
| Defective Mismatch Repair Associated With MLH1 | R-HSA-5545483 | 2.568501e-01 | 0.590 | 0 | 0 |
| Impaired BRCA2 translocation to the nucleus | R-HSA-9709275 | 2.568501e-01 | 0.590 | 0 | 0 |
| Impaired BRCA2 binding to SEM1 (DSS1) | R-HSA-9763198 | 2.568501e-01 | 0.590 | 0 | 0 |
| Defective SLC2A1 causes GLUT1 deficiency syndrome 1 (GLUT1DS1) | R-HSA-5619043 | 2.568501e-01 | 0.590 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 1.705485e-01 | 0.768 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 1.705485e-01 | 0.768 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 2.240422e-01 | 0.650 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 2.240422e-01 | 0.650 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 2.240422e-01 | 0.650 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 2.240422e-01 | 0.650 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 2.240422e-01 | 0.650 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 2.240422e-01 | 0.650 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 1.871565e-01 | 0.728 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 1.871565e-01 | 0.728 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 1.871565e-01 | 0.728 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 1.871565e-01 | 0.728 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 1.871565e-01 | 0.728 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 1.871565e-01 | 0.728 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 1.871565e-01 | 0.728 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 1.871565e-01 | 0.728 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 1.871565e-01 | 0.728 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 1.871565e-01 | 0.728 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 1.871565e-01 | 0.728 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 2.785647e-01 | 0.555 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 2.785647e-01 | 0.555 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 2.785647e-01 | 0.555 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 2.785647e-01 | 0.555 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 2.250707e-01 | 0.648 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 2.250707e-01 | 0.648 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 2.250707e-01 | 0.648 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 1.857707e-01 | 0.731 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 1.857707e-01 | 0.731 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 2.159441e-01 | 0.666 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 2.159441e-01 | 0.666 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 2.642840e-01 | 0.578 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 2.642840e-01 | 0.578 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 2.642840e-01 | 0.578 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 2.046313e-01 | 0.689 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 2.473258e-01 | 0.607 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 1.930862e-01 | 0.714 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 3.042292e-01 | 0.517 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 3.042292e-01 | 0.517 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 3.042292e-01 | 0.517 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 1.713538e-01 | 0.766 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 2.158854e-01 | 0.666 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 2.796058e-01 | 0.553 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 2.796058e-01 | 0.553 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 2.582797e-01 | 0.588 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.582797e-01 | 0.588 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 1.892556e-01 | 0.723 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 1.775431e-01 | 0.751 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 2.395420e-01 | 0.621 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 2.395420e-01 | 0.621 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 1.667523e-01 | 0.778 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 1.667523e-01 | 0.778 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 3.124852e-01 | 0.505 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 3.124852e-01 | 0.505 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 2.862619e-01 | 0.543 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 2.639260e-01 | 0.579 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 2.444635e-01 | 0.612 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 2.272378e-01 | 0.644 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 1.852391e-01 | 0.732 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 2.666690e-01 | 0.574 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 2.889053e-01 | 0.539 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 1.665802e-01 | 0.778 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 1.890739e-01 | 0.723 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 2.893943e-01 | 0.539 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 2.893943e-01 | 0.539 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 2.031896e-01 | 0.692 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 2.675538e-01 | 0.573 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 2.666956e-01 | 0.574 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 2.849898e-01 | 0.545 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 2.849898e-01 | 0.545 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 2.825882e-01 | 0.549 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 3.001707e-01 | 0.523 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 3.001707e-01 | 0.523 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 2.286824e-01 | 0.641 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 2.286824e-01 | 0.641 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 2.264605e-01 | 0.645 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 2.264605e-01 | 0.645 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 2.536681e-01 | 0.596 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 2.536681e-01 | 0.596 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 1.964294e-01 | 0.707 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 3.006882e-01 | 0.522 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 2.038202e-01 | 0.691 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 2.801462e-01 | 0.553 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 2.482371e-01 | 0.605 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 2.380457e-01 | 0.623 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 1.851615e-01 | 0.732 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 2.019987e-01 | 0.695 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 2.109714e-01 | 0.676 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 1.713538e-01 | 0.766 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 3.225448e-01 | 0.491 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 3.307423e-01 | 0.481 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 1.996863e-01 | 0.700 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 2.639260e-01 | 0.579 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 2.159441e-01 | 0.666 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 2.228750e-01 | 0.652 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 2.487910e-01 | 0.604 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 1.750398e-01 | 0.757 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 2.966359e-01 | 0.528 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 2.771936e-01 | 0.557 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 1.978952e-01 | 0.704 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 3.143477e-01 | 0.503 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 2.639260e-01 | 0.579 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 1.906865e-01 | 0.720 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 2.642840e-01 | 0.578 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 2.473258e-01 | 0.607 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 3.042292e-01 | 0.517 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 1.775431e-01 | 0.751 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 2.272378e-01 | 0.644 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 1.736719e-01 | 0.760 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 1.906084e-01 | 0.720 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 1.871565e-01 | 0.728 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 2.666956e-01 | 0.574 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 2.839291e-01 | 0.547 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 2.159441e-01 | 0.666 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 1.775431e-01 | 0.751 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 2.395420e-01 | 0.621 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 2.862619e-01 | 0.543 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 2.444635e-01 | 0.612 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 2.166676e-01 | 0.664 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 2.653259e-01 | 0.576 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 1.906663e-01 | 0.720 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 3.133489e-01 | 0.504 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 1.685758e-01 | 0.773 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 2.098583e-01 | 0.678 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 1.943567e-01 | 0.711 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 1.707248e-01 | 0.768 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 2.118180e-01 | 0.674 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 1.852391e-01 | 0.732 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.891522e-01 | 0.723 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 2.653259e-01 | 0.576 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 1.875181e-01 | 0.727 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 2.815722e-01 | 0.550 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 1.782796e-01 | 0.749 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 2.240422e-01 | 0.650 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 1.857707e-01 | 0.731 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 1.820181e-01 | 0.740 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 1.687257e-01 | 0.773 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 2.886188e-01 | 0.540 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 2.870576e-01 | 0.542 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 2.870576e-01 | 0.542 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 2.154010e-01 | 0.667 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 2.743273e-01 | 0.562 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 2.487910e-01 | 0.604 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 2.930646e-01 | 0.533 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 1.788084e-01 | 0.748 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 2.862619e-01 | 0.543 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 2.431739e-01 | 0.614 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 1.820181e-01 | 0.740 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 3.048776e-01 | 0.516 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 2.240422e-01 | 0.650 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 2.159441e-01 | 0.666 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 2.851886e-01 | 0.545 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 2.547505e-01 | 0.594 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 2.038202e-01 | 0.691 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 2.448629e-01 | 0.611 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 2.279710e-01 | 0.642 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 2.666690e-01 | 0.574 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 2.484730e-01 | 0.605 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 2.484730e-01 | 0.605 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 2.212304e-01 | 0.655 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 2.212304e-01 | 0.655 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 2.314380e-01 | 0.636 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 3.042292e-01 | 0.517 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 1.819256e-01 | 0.740 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 1.903426e-01 | 0.720 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 2.796058e-01 | 0.553 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 2.639260e-01 | 0.579 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 2.653259e-01 | 0.576 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 1.985313e-01 | 0.702 | 0 | 0 |
| SDK interactions | R-HSA-373756 | 2.568501e-01 | 0.590 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 2.568501e-01 | 0.590 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 1.705485e-01 | 0.768 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 2.240422e-01 | 0.650 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 2.240422e-01 | 0.650 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 2.240422e-01 | 0.650 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 2.240422e-01 | 0.650 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 1.871565e-01 | 0.728 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 1.857707e-01 | 0.731 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 1.857707e-01 | 0.731 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 1.793471e-01 | 0.746 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 2.582797e-01 | 0.588 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 2.676685e-01 | 0.572 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 3.099574e-01 | 0.509 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 2.616119e-01 | 0.582 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 2.743273e-01 | 0.562 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 2.809861e-01 | 0.551 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 2.267431e-01 | 0.644 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 2.380800e-01 | 0.623 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 3.124852e-01 | 0.505 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 2.272378e-01 | 0.644 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 3.042292e-01 | 0.517 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 2.395420e-01 | 0.621 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 2.431739e-01 | 0.614 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 1.729533e-01 | 0.762 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 2.642840e-01 | 0.578 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 2.642840e-01 | 0.578 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 2.796058e-01 | 0.553 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 2.471832e-01 | 0.607 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 2.676685e-01 | 0.572 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 3.089385e-01 | 0.510 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 2.228750e-01 | 0.652 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 1.930862e-01 | 0.714 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 1.907929e-01 | 0.719 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 2.159441e-01 | 0.666 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 2.159441e-01 | 0.666 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 2.642840e-01 | 0.578 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 2.228750e-01 | 0.652 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 1.676765e-01 | 0.776 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 2.487910e-01 | 0.604 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 1.793471e-01 | 0.746 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 2.642840e-01 | 0.578 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 3.042292e-01 | 0.517 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 2.487910e-01 | 0.604 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 2.031896e-01 | 0.692 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 1.867325e-01 | 0.729 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 3.147630e-01 | 0.502 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 3.308374e-01 | 0.480 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 3.316073e-01 | 0.479 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 3.316073e-01 | 0.479 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 3.316073e-01 | 0.479 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 3.328150e-01 | 0.478 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 3.328150e-01 | 0.478 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 3.328150e-01 | 0.478 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 3.328150e-01 | 0.478 | 0 | 0 |
| Formation of lateral plate mesoderm | R-HSA-9758920 | 3.328150e-01 | 0.478 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 3.328150e-01 | 0.478 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 3.328150e-01 | 0.478 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 3.360101e-01 | 0.474 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 3.361235e-01 | 0.474 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 3.401224e-01 | 0.468 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 3.401224e-01 | 0.468 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 3.435994e-01 | 0.464 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 3.435994e-01 | 0.464 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 3.435994e-01 | 0.464 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 3.444004e-01 | 0.463 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 3.444004e-01 | 0.463 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 3.444004e-01 | 0.463 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 3.456823e-01 | 0.461 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 3.456823e-01 | 0.461 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 3.456823e-01 | 0.461 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 3.473575e-01 | 0.459 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 3.474897e-01 | 0.459 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 3.474897e-01 | 0.459 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 3.481023e-01 | 0.458 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 3.481023e-01 | 0.458 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 3.509542e-01 | 0.455 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 3.509542e-01 | 0.455 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 3.536318e-01 | 0.451 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 3.551737e-01 | 0.450 | 0 | 0 |
| ARL13B-mediated ciliary trafficking of INPP5E | R-HSA-5624958 | 3.593680e-01 | 0.444 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 3.593680e-01 | 0.444 | 0 | 0 |
| Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) | R-HSA-5660686 | 3.593680e-01 | 0.444 | 0 | 0 |
| Defective GALE causes EDG | R-HSA-5609977 | 3.593680e-01 | 0.444 | 0 | 0 |
| Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) | R-HSA-5619101 | 3.593680e-01 | 0.444 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9630794 | 3.593680e-01 | 0.444 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9632700 | 3.593680e-01 | 0.444 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 3.593680e-01 | 0.444 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 3.593680e-01 | 0.444 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 3.593680e-01 | 0.444 | 0 | 0 |
| TALDO1 deficiency: failed conversion of Fru(6)P, E4P to SH7P, GA3P | R-HSA-6791462 | 3.593680e-01 | 0.444 | 0 | 0 |
| Defective HK1 causes hexokinase deficiency (HK deficiency) | R-HSA-5619056 | 3.593680e-01 | 0.444 | 0 | 0 |
| TALDO1 deficiency: failed conversion of SH7P, GA3P to Fru(6)P, E4P | R-HSA-6791055 | 3.593680e-01 | 0.444 | 0 | 0 |
| Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3 | R-HSA-5083628 | 3.593680e-01 | 0.444 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 3.593680e-01 | 0.444 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 3.593680e-01 | 0.444 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 3.593680e-01 | 0.444 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p16INK4A Defects | R-HSA-9630750 | 3.593680e-01 | 0.444 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects | R-HSA-9632693 | 3.593680e-01 | 0.444 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 3.593680e-01 | 0.444 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 3.593680e-01 | 0.444 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 3.593680e-01 | 0.444 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 3.597052e-01 | 0.444 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 3.597052e-01 | 0.444 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 3.610445e-01 | 0.442 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 3.630319e-01 | 0.440 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 3.634737e-01 | 0.440 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 3.651834e-01 | 0.437 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 3.661024e-01 | 0.436 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 3.661024e-01 | 0.436 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 3.661024e-01 | 0.436 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 3.725958e-01 | 0.429 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 3.725958e-01 | 0.429 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 3.725958e-01 | 0.429 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 3.728343e-01 | 0.428 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 3.756310e-01 | 0.425 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 3.773157e-01 | 0.423 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 3.789361e-01 | 0.421 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 3.792864e-01 | 0.421 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 3.805194e-01 | 0.420 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 3.832461e-01 | 0.417 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 3.843561e-01 | 0.415 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 3.843561e-01 | 0.415 | 0 | 0 |
| Chylomicron clearance | R-HSA-8964026 | 3.858312e-01 | 0.414 | 0 | 0 |
| Toxicity of botulinum toxin type F (botF) | R-HSA-5250981 | 3.858312e-01 | 0.414 | 0 | 0 |
| Toxicity of botulinum toxin type D (botD) | R-HSA-5250955 | 3.858312e-01 | 0.414 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 3.858312e-01 | 0.414 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 3.858312e-01 | 0.414 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 3.921652e-01 | 0.407 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 3.921652e-01 | 0.407 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 3.925560e-01 | 0.406 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 3.951520e-01 | 0.403 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 3.976629e-01 | 0.400 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 3.976629e-01 | 0.400 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 3.976629e-01 | 0.400 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 3.976629e-01 | 0.400 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 3.976629e-01 | 0.400 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 4.000764e-01 | 0.398 | 1 | 1 |
| Downstream TCR signaling | R-HSA-202424 | 4.004536e-01 | 0.397 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 4.009545e-01 | 0.397 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 4.015872e-01 | 0.396 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 4.015872e-01 | 0.396 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 4.015872e-01 | 0.396 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 4.048968e-01 | 0.393 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 4.086343e-01 | 0.389 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 4.099090e-01 | 0.387 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 4.120092e-01 | 0.385 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 4.120092e-01 | 0.385 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 4.120092e-01 | 0.385 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 4.173104e-01 | 0.380 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 4.181948e-01 | 0.379 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 4.181948e-01 | 0.379 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 4.181948e-01 | 0.379 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 4.205625e-01 | 0.376 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 4.237197e-01 | 0.373 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 4.237197e-01 | 0.373 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 4.237197e-01 | 0.373 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 4.237197e-01 | 0.373 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 4.237197e-01 | 0.373 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 4.237197e-01 | 0.373 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 4.257573e-01 | 0.371 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 4.285593e-01 | 0.368 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 4.302421e-01 | 0.366 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 4.369216e-01 | 0.360 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis | R-HSA-9632974 | 4.369216e-01 | 0.360 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 4.369216e-01 | 0.360 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 4.369216e-01 | 0.360 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 4.418892e-01 | 0.355 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 4.440818e-01 | 0.353 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 4.440818e-01 | 0.353 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 4.440818e-01 | 0.353 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 4.440818e-01 | 0.353 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 4.446891e-01 | 0.352 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 4.446891e-01 | 0.352 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 4.446891e-01 | 0.352 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 4.446891e-01 | 0.352 | 0 | 0 |
| Protein folding | R-HSA-391251 | 4.461698e-01 | 0.350 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 4.461698e-01 | 0.350 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 4.461698e-01 | 0.350 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 4.477486e-01 | 0.349 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 4.477486e-01 | 0.349 | 0 | 0 |
| Essential pentosuria | R-HSA-5662853 | 4.477486e-01 | 0.349 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 4.477486e-01 | 0.349 | 0 | 0 |
| Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1 | R-HSA-5083633 | 4.477486e-01 | 0.349 | 0 | 0 |
| Defective SLC12A1 causes Bartter syndrome 1 (BS1) | R-HSA-5619104 | 4.477486e-01 | 0.349 | 0 | 0 |
| Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2 | R-HSA-5083629 | 4.477486e-01 | 0.349 | 0 | 0 |
| Signalling to ERK5 | R-HSA-198765 | 4.477486e-01 | 0.349 | 0 | 0 |
| DSCAM interactions | R-HSA-376172 | 4.477486e-01 | 0.349 | 0 | 0 |
| Diseases of cellular response to stress | R-HSA-9675132 | 4.477486e-01 | 0.349 | 0 | 0 |
| Diseases of Cellular Senescence | R-HSA-9630747 | 4.477486e-01 | 0.349 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 4.477486e-01 | 0.349 | 0 | 0 |
| ATF6B (ATF6-beta) activates chaperones | R-HSA-8874177 | 4.477486e-01 | 0.349 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 4.509223e-01 | 0.346 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 4.538443e-01 | 0.343 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 4.576489e-01 | 0.339 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 4.589544e-01 | 0.338 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 4.589544e-01 | 0.338 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 4.621774e-01 | 0.335 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 4.621774e-01 | 0.335 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 4.621774e-01 | 0.335 | 0 | 0 |
| IL-6-type cytokine receptor ligand interactions | R-HSA-6788467 | 4.621774e-01 | 0.335 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 4.621774e-01 | 0.335 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 4.650638e-01 | 0.332 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 4.655646e-01 | 0.332 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 4.697248e-01 | 0.328 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 4.728898e-01 | 0.325 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 4.767893e-01 | 0.322 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 4.767893e-01 | 0.322 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 4.767893e-01 | 0.322 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 4.767893e-01 | 0.322 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 4.767893e-01 | 0.322 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 4.774522e-01 | 0.321 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 4.798519e-01 | 0.319 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 4.825820e-01 | 0.316 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 4.825820e-01 | 0.316 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 4.829024e-01 | 0.316 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 4.854746e-01 | 0.314 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 4.856089e-01 | 0.314 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 4.856089e-01 | 0.314 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 4.856089e-01 | 0.314 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 4.856089e-01 | 0.314 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 4.856089e-01 | 0.314 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 4.856089e-01 | 0.314 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 4.856089e-01 | 0.314 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 4.856342e-01 | 0.314 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 4.950308e-01 | 0.305 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 4.994739e-01 | 0.301 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 4.994739e-01 | 0.301 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 4.994739e-01 | 0.301 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 4.994739e-01 | 0.301 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 4.994739e-01 | 0.301 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 4.996763e-01 | 0.301 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 5.015804e-01 | 0.300 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 5.015804e-01 | 0.300 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 5.067510e-01 | 0.295 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 5.081488e-01 | 0.294 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 5.098493e-01 | 0.293 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 5.103788e-01 | 0.292 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 5.103788e-01 | 0.292 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 5.109677e-01 | 0.292 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 5.146338e-01 | 0.289 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 5.164709e-01 | 0.287 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 5.199152e-01 | 0.284 | 0 | 0 |
| Activated NTRK3 signals through PLCG1 | R-HSA-9034793 | 5.239408e-01 | 0.281 | 0 | 0 |
| PLC-gamma1 signalling | R-HSA-167021 | 5.239408e-01 | 0.281 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 5.239408e-01 | 0.281 | 0 | 0 |
| Defective DPM1 causes DPM1-CDG | R-HSA-4717374 | 5.239408e-01 | 0.281 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 5.239408e-01 | 0.281 | 0 | 0 |
| Defective MAOA causes BRUNS | R-HSA-5579012 | 5.239408e-01 | 0.281 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 5.239408e-01 | 0.281 | 0 | 0 |
| Defective DPM3 causes DPM3-CDG | R-HSA-4719360 | 5.239408e-01 | 0.281 | 0 | 0 |
| Defective SLC7A7 causes lysinuric protein intolerance (LPI) | R-HSA-5660862 | 5.239408e-01 | 0.281 | 0 | 0 |
| Defective ABCC2 causes DJS | R-HSA-5679001 | 5.239408e-01 | 0.281 | 0 | 0 |
| Defective DPM2 causes DPM2-CDG | R-HSA-4719377 | 5.239408e-01 | 0.281 | 0 | 0 |
| MET activates STAT3 | R-HSA-8875791 | 5.239408e-01 | 0.281 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 5.239408e-01 | 0.281 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 5.239408e-01 | 0.281 | 0 | 0 |
| Intracellular oxygen transport | R-HSA-8981607 | 5.239408e-01 | 0.281 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 5.239408e-01 | 0.281 | 0 | 0 |
| FasL/ CD95L signaling | R-HSA-75157 | 5.239408e-01 | 0.281 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 5.284193e-01 | 0.277 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 5.315838e-01 | 0.274 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 5.315838e-01 | 0.274 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 5.315838e-01 | 0.274 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 5.315838e-01 | 0.274 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 5.315838e-01 | 0.274 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 5.315838e-01 | 0.274 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 5.315838e-01 | 0.274 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 5.315838e-01 | 0.274 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 5.315838e-01 | 0.274 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 5.336795e-01 | 0.273 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 5.354081e-01 | 0.271 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 5.354081e-01 | 0.271 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 5.383566e-01 | 0.269 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 5.384718e-01 | 0.269 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 5.386314e-01 | 0.269 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 5.386314e-01 | 0.269 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 5.415674e-01 | 0.266 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 5.415674e-01 | 0.266 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 5.415674e-01 | 0.266 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 5.415674e-01 | 0.266 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 5.415674e-01 | 0.266 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 5.415674e-01 | 0.266 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 5.415674e-01 | 0.266 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 5.415674e-01 | 0.266 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 5.443024e-01 | 0.264 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 5.443024e-01 | 0.264 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 5.468780e-01 | 0.262 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 5.488626e-01 | 0.261 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 5.493205e-01 | 0.260 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 5.493205e-01 | 0.260 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 5.493205e-01 | 0.260 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 5.493205e-01 | 0.260 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 5.493205e-01 | 0.260 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 5.580832e-01 | 0.253 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 5.681257e-01 | 0.246 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 5.681257e-01 | 0.246 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 5.698272e-01 | 0.244 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 5.698272e-01 | 0.244 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 5.698272e-01 | 0.244 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 5.698272e-01 | 0.244 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 5.698272e-01 | 0.244 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 5.698272e-01 | 0.244 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 5.698272e-01 | 0.244 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 5.734185e-01 | 0.242 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 5.736756e-01 | 0.241 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 5.746680e-01 | 0.241 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 5.746680e-01 | 0.241 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 5.746680e-01 | 0.241 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 5.746680e-01 | 0.241 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 5.746680e-01 | 0.241 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 5.746680e-01 | 0.241 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 5.746680e-01 | 0.241 | 0 | 0 |
| Metal sequestration by antimicrobial proteins | R-HSA-6799990 | 5.746680e-01 | 0.241 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 5.826869e-01 | 0.235 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 5.865160e-01 | 0.232 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 5.895393e-01 | 0.229 | 0 | 0 |
| Activated NTRK2 signals through PLCG1 | R-HSA-9026527 | 5.896247e-01 | 0.229 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 5.896247e-01 | 0.229 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 5.896247e-01 | 0.229 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 5.896247e-01 | 0.229 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 5.896247e-01 | 0.229 | 0 | 0 |
| Defective SLC7A9 causes cystinuria (CSNU) | R-HSA-5660883 | 5.896247e-01 | 0.229 | 0 | 0 |
| Defective SLC3A1 causes cystinuria (CSNU) | R-HSA-5619113 | 5.896247e-01 | 0.229 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 5.896247e-01 | 0.229 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 5.896247e-01 | 0.229 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 5.896247e-01 | 0.229 | 0 | 0 |
| Toxicity of tetanus toxin (tetX) | R-HSA-5250982 | 5.896247e-01 | 0.229 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 5.898762e-01 | 0.229 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 5.901045e-01 | 0.229 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 5.903385e-01 | 0.229 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 5.903385e-01 | 0.229 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 5.903385e-01 | 0.229 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 5.913270e-01 | 0.228 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 5.913270e-01 | 0.228 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 5.913270e-01 | 0.228 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 5.931968e-01 | 0.227 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 5.933290e-01 | 0.227 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 5.965396e-01 | 0.224 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 5.965396e-01 | 0.224 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 5.965396e-01 | 0.224 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 5.979324e-01 | 0.223 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 5.979324e-01 | 0.223 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 5.979324e-01 | 0.223 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 6.026216e-01 | 0.220 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 6.026216e-01 | 0.220 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 6.026216e-01 | 0.220 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 6.072271e-01 | 0.217 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 6.077017e-01 | 0.216 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 6.077337e-01 | 0.216 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 6.112637e-01 | 0.214 | 0 | 0 |
| Presynaptic depolarization and calcium channel opening | R-HSA-112308 | 6.147841e-01 | 0.211 | 0 | 0 |
| Regulation of gene expression in early pancreatic precursor cells | R-HSA-210747 | 6.147841e-01 | 0.211 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 6.147841e-01 | 0.211 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 6.147841e-01 | 0.211 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 6.147841e-01 | 0.211 | 0 | 0 |
| Prostanoid ligand receptors | R-HSA-391908 | 6.147841e-01 | 0.211 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 6.220755e-01 | 0.206 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 6.221294e-01 | 0.206 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 6.237762e-01 | 0.205 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 6.238059e-01 | 0.205 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 6.238059e-01 | 0.205 | 0 | 0 |
| Immune System | R-HSA-168256 | 6.258189e-01 | 0.204 | 1 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 6.265001e-01 | 0.203 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 6.304908e-01 | 0.200 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 6.316024e-01 | 0.200 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 6.337190e-01 | 0.198 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 6.337190e-01 | 0.198 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 6.356739e-01 | 0.197 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 6.358273e-01 | 0.197 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 6.364611e-01 | 0.196 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 6.373120e-01 | 0.196 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 6.414276e-01 | 0.193 | 0 | 0 |
| FGFR1c and Klotho ligand binding and activation | R-HSA-190374 | 6.462493e-01 | 0.190 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 6.462493e-01 | 0.190 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 6.462493e-01 | 0.190 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 6.462493e-01 | 0.190 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 6.462493e-01 | 0.190 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 6.462493e-01 | 0.190 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 6.462493e-01 | 0.190 | 0 | 0 |
| PTK6 Activates STAT3 | R-HSA-8849474 | 6.462493e-01 | 0.190 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 6.462493e-01 | 0.190 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 6.462493e-01 | 0.190 | 0 | 0 |
| Pyrophosphate hydrolysis | R-HSA-71737 | 6.462493e-01 | 0.190 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 6.462493e-01 | 0.190 | 0 | 0 |
| Toxicity of botulinum toxin type G (botG) | R-HSA-5250989 | 6.462493e-01 | 0.190 | 0 | 0 |
| Zinc efflux and compartmentalization by the SLC30 family | R-HSA-435368 | 6.462493e-01 | 0.190 | 0 | 0 |
| Assembly of Viral Components at the Budding Site | R-HSA-168316 | 6.462493e-01 | 0.190 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 6.494903e-01 | 0.187 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 6.498736e-01 | 0.187 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 6.498736e-01 | 0.187 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 6.498736e-01 | 0.187 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 6.498736e-01 | 0.187 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 6.519015e-01 | 0.186 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 6.519307e-01 | 0.186 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 6.519307e-01 | 0.186 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 6.519307e-01 | 0.186 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 6.519307e-01 | 0.186 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 6.519307e-01 | 0.186 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 6.535562e-01 | 0.185 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 6.628820e-01 | 0.179 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 6.630795e-01 | 0.178 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 6.641580e-01 | 0.178 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 6.670614e-01 | 0.176 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 6.704048e-01 | 0.174 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 6.704048e-01 | 0.174 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 6.704048e-01 | 0.174 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 6.747092e-01 | 0.171 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 6.747092e-01 | 0.171 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 6.747092e-01 | 0.171 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 6.747092e-01 | 0.171 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 6.747092e-01 | 0.171 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 6.770437e-01 | 0.169 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 6.770437e-01 | 0.169 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 6.770437e-01 | 0.169 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 6.770437e-01 | 0.169 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 6.778818e-01 | 0.169 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 6.791382e-01 | 0.168 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 6.827931e-01 | 0.166 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 6.827931e-01 | 0.166 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 6.827931e-01 | 0.166 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 6.855027e-01 | 0.164 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 6.858791e-01 | 0.164 | 1 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 6.861636e-01 | 0.164 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 6.861636e-01 | 0.164 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 6.861636e-01 | 0.164 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 6.888243e-01 | 0.162 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 6.937065e-01 | 0.159 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 6.950634e-01 | 0.158 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 6.950634e-01 | 0.158 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 6.950634e-01 | 0.158 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 6.950634e-01 | 0.158 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 6.950634e-01 | 0.158 | 0 | 0 |
| Pentose phosphate pathway disease | R-HSA-6791465 | 6.950634e-01 | 0.158 | 0 | 0 |
| Synthesis of PS | R-HSA-1483101 | 6.950634e-01 | 0.158 | 0 | 0 |
| Synthesis of dolichyl-phosphate mannose | R-HSA-162699 | 6.950634e-01 | 0.158 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 6.950634e-01 | 0.158 | 0 | 0 |
| Release of Hh-Np from the secreting cell | R-HSA-5362798 | 6.950634e-01 | 0.158 | 0 | 0 |
| TRAIL signaling | R-HSA-75158 | 6.950634e-01 | 0.158 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 6.965512e-01 | 0.157 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 6.965512e-01 | 0.157 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 6.965512e-01 | 0.157 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 6.965512e-01 | 0.157 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 6.982946e-01 | 0.156 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 6.982946e-01 | 0.156 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 6.997003e-01 | 0.155 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 7.049433e-01 | 0.152 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 7.067216e-01 | 0.151 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 7.069537e-01 | 0.151 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 7.165614e-01 | 0.145 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 7.165614e-01 | 0.145 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 7.165614e-01 | 0.145 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 7.165614e-01 | 0.145 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 7.165614e-01 | 0.145 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 7.165614e-01 | 0.145 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 7.175795e-01 | 0.144 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 7.175795e-01 | 0.144 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 7.175795e-01 | 0.144 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 7.175795e-01 | 0.144 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 7.175795e-01 | 0.144 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 7.175795e-01 | 0.144 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 7.175795e-01 | 0.144 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 7.226738e-01 | 0.141 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 7.236271e-01 | 0.140 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 7.265317e-01 | 0.139 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 7.265317e-01 | 0.139 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 7.265317e-01 | 0.139 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 7.281797e-01 | 0.138 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 7.317339e-01 | 0.136 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 7.331480e-01 | 0.135 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 7.331480e-01 | 0.135 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 7.331480e-01 | 0.135 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 7.371441e-01 | 0.132 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 7.371441e-01 | 0.132 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 7.371441e-01 | 0.132 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 7.371441e-01 | 0.132 | 0 | 0 |
| Branched-chain ketoacid dehydrogenase kinase deficiency | R-HSA-9912481 | 7.371441e-01 | 0.132 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 7.371441e-01 | 0.132 | 0 | 0 |
| MET Receptor Activation | R-HSA-6806942 | 7.371441e-01 | 0.132 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 7.371441e-01 | 0.132 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 7.371441e-01 | 0.132 | 0 | 0 |
| Lactose synthesis | R-HSA-5653890 | 7.371441e-01 | 0.132 | 0 | 0 |
| Leukotriene receptors | R-HSA-391906 | 7.371441e-01 | 0.132 | 0 | 0 |
| HDL clearance | R-HSA-8964011 | 7.371441e-01 | 0.132 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 7.371441e-01 | 0.132 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 7.371441e-01 | 0.132 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 7.395381e-01 | 0.131 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 7.399949e-01 | 0.131 | 0 | 0 |
| Vitamin C (ascorbate) metabolism | R-HSA-196836 | 7.407216e-01 | 0.130 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 7.417064e-01 | 0.130 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 7.417064e-01 | 0.130 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 7.417064e-01 | 0.130 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 7.445327e-01 | 0.128 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 7.463038e-01 | 0.127 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 7.463038e-01 | 0.127 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 7.463038e-01 | 0.127 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 7.470322e-01 | 0.127 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 7.556701e-01 | 0.122 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 7.570353e-01 | 0.121 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 7.615558e-01 | 0.118 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 7.619742e-01 | 0.118 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 7.632143e-01 | 0.117 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 7.632143e-01 | 0.117 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 7.632143e-01 | 0.117 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 7.632143e-01 | 0.117 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 7.632143e-01 | 0.117 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 7.632675e-01 | 0.117 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 7.638212e-01 | 0.117 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 7.699087e-01 | 0.114 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 7.723543e-01 | 0.112 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 7.724811e-01 | 0.112 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 7.724811e-01 | 0.112 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 7.724811e-01 | 0.112 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 7.724811e-01 | 0.112 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 7.724811e-01 | 0.112 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 7.724811e-01 | 0.112 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 7.724811e-01 | 0.112 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 7.727881e-01 | 0.112 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 7.734198e-01 | 0.112 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 7.734198e-01 | 0.112 | 0 | 0 |
| Progressive trimming of alpha-1,2-linked mannose residues from Man9/8/7GlcNAc2 to produce Man5GlcNAc2 | R-HSA-964827 | 7.734198e-01 | 0.112 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 7.734198e-01 | 0.112 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 7.734198e-01 | 0.112 | 0 | 0 |
| DAG1 core M1 glycosylations | R-HSA-8932506 | 7.734198e-01 | 0.112 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 7.734198e-01 | 0.112 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 7.734198e-01 | 0.112 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 7.734198e-01 | 0.112 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 7.734198e-01 | 0.112 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 7.734198e-01 | 0.112 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 7.734198e-01 | 0.112 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 7.734198e-01 | 0.112 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 7.734198e-01 | 0.112 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 7.734198e-01 | 0.112 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 7.792355e-01 | 0.108 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 7.801979e-01 | 0.108 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 7.819733e-01 | 0.107 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 7.819733e-01 | 0.107 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 7.819733e-01 | 0.107 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 7.820441e-01 | 0.107 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 7.820441e-01 | 0.107 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 7.820441e-01 | 0.107 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 7.823715e-01 | 0.107 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 7.840948e-01 | 0.106 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 7.840948e-01 | 0.106 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 7.840948e-01 | 0.106 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 7.840948e-01 | 0.106 | 0 | 0 |
| Cellular hexose transport | R-HSA-189200 | 7.840948e-01 | 0.106 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 7.840948e-01 | 0.106 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 7.849539e-01 | 0.105 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 7.850425e-01 | 0.105 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 7.894624e-01 | 0.103 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 7.919952e-01 | 0.101 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 7.962671e-01 | 0.099 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 7.962671e-01 | 0.099 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 7.962671e-01 | 0.099 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 7.962671e-01 | 0.099 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 7.962671e-01 | 0.099 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 7.966558e-01 | 0.099 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 7.985757e-01 | 0.098 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 7.993869e-01 | 0.097 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 8.034273e-01 | 0.095 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 8.034273e-01 | 0.095 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 8.034273e-01 | 0.095 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 8.044846e-01 | 0.094 | 0 | 0 |
| ALKBH3 mediated reversal of alkylation damage | R-HSA-112126 | 8.046911e-01 | 0.094 | 0 | 0 |
| DAG1 core M2 glycosylations | R-HSA-8932504 | 8.046911e-01 | 0.094 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 8.046911e-01 | 0.094 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 8.046911e-01 | 0.094 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 8.046911e-01 | 0.094 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | R-HSA-8939242 | 8.046911e-01 | 0.094 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 8.046911e-01 | 0.094 | 0 | 0 |
| Fructose biosynthesis | R-HSA-5652227 | 8.046911e-01 | 0.094 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 8.046911e-01 | 0.094 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 8.046911e-01 | 0.094 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 8.046911e-01 | 0.094 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 8.046911e-01 | 0.094 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 8.046911e-01 | 0.094 | 0 | 0 |
| Toxicity of botulinum toxin type B (botB) | R-HSA-5250958 | 8.046911e-01 | 0.094 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 8.046911e-01 | 0.094 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 8.053767e-01 | 0.094 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 8.079841e-01 | 0.093 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 8.105639e-01 | 0.091 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 8.110593e-01 | 0.091 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 8.134151e-01 | 0.090 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 8.139841e-01 | 0.089 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 8.139841e-01 | 0.089 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 8.178232e-01 | 0.087 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 8.178232e-01 | 0.087 | 0 | 0 |
| Glycine degradation | R-HSA-6783984 | 8.178232e-01 | 0.087 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 8.178232e-01 | 0.087 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 8.178232e-01 | 0.087 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 8.212822e-01 | 0.086 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 8.212822e-01 | 0.086 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 8.237153e-01 | 0.084 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 8.292227e-01 | 0.081 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 8.316480e-01 | 0.080 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 8.316480e-01 | 0.080 | 0 | 0 |
| Hypusine synthesis from eIF5A-lysine | R-HSA-204626 | 8.316480e-01 | 0.080 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 8.316480e-01 | 0.080 | 0 | 0 |
| Enzymatic degradation of Dopamine by monoamine oxidase | R-HSA-379398 | 8.316480e-01 | 0.080 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 8.316480e-01 | 0.080 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 8.316480e-01 | 0.080 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 8.316480e-01 | 0.080 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 8.316480e-01 | 0.080 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 8.316480e-01 | 0.080 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 8.316480e-01 | 0.080 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 8.316480e-01 | 0.080 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 8.316480e-01 | 0.080 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 8.347927e-01 | 0.078 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 8.373118e-01 | 0.077 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 8.373118e-01 | 0.077 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 8.373118e-01 | 0.077 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 8.373118e-01 | 0.077 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 8.373118e-01 | 0.077 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 8.377345e-01 | 0.077 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 8.377345e-01 | 0.077 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 8.433810e-01 | 0.074 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 8.434012e-01 | 0.074 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 8.458235e-01 | 0.073 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 8.458235e-01 | 0.073 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 8.470665e-01 | 0.072 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 8.484511e-01 | 0.071 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 8.508563e-01 | 0.070 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 8.548857e-01 | 0.068 | 0 | 0 |
| TET1,2,3 and TDG demethylate DNA | R-HSA-5221030 | 8.548857e-01 | 0.068 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 8.548857e-01 | 0.068 | 0 | 0 |
| Metabolism of serotonin | R-HSA-380612 | 8.548857e-01 | 0.068 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 8.548857e-01 | 0.068 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 8.548857e-01 | 0.068 | 0 | 0 |
| Arachidonate production from DAG | R-HSA-426048 | 8.548857e-01 | 0.068 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 8.548857e-01 | 0.068 | 0 | 0 |
| Enzymatic degradation of dopamine by COMT | R-HSA-379397 | 8.548857e-01 | 0.068 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 8.548857e-01 | 0.068 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 8.548928e-01 | 0.068 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 8.548928e-01 | 0.068 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 8.566821e-01 | 0.067 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 8.569727e-01 | 0.067 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 8.586315e-01 | 0.066 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 8.624711e-01 | 0.064 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 8.667421e-01 | 0.062 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 8.668245e-01 | 0.062 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 8.707214e-01 | 0.060 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 8.707214e-01 | 0.060 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 8.707214e-01 | 0.060 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 8.707214e-01 | 0.060 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 8.707214e-01 | 0.060 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 8.707214e-01 | 0.060 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 8.749170e-01 | 0.058 | 0 | 0 |
| DAG1 core M3 glycosylations | R-HSA-8932505 | 8.749170e-01 | 0.058 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 8.749170e-01 | 0.058 | 0 | 0 |
| FGFRL1 modulation of FGFR1 signaling | R-HSA-5658623 | 8.749170e-01 | 0.058 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 8.749170e-01 | 0.058 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 8.749170e-01 | 0.058 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 8.749170e-01 | 0.058 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 8.749170e-01 | 0.058 | 0 | 0 |
| Inorganic anion exchange by SLC26 transporters | R-HSA-427601 | 8.749170e-01 | 0.058 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 8.788896e-01 | 0.056 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 8.788896e-01 | 0.056 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 8.788896e-01 | 0.056 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 8.794544e-01 | 0.056 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 8.794544e-01 | 0.056 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 8.794544e-01 | 0.056 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 8.801024e-01 | 0.055 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 8.801024e-01 | 0.055 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 8.801024e-01 | 0.055 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 8.819686e-01 | 0.055 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 8.824032e-01 | 0.054 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 8.834269e-01 | 0.054 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 8.849463e-01 | 0.053 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 8.849463e-01 | 0.053 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 8.849463e-01 | 0.053 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 8.849463e-01 | 0.053 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 8.849463e-01 | 0.053 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 8.869936e-01 | 0.052 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 8.888842e-01 | 0.051 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 8.910761e-01 | 0.050 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 8.921842e-01 | 0.050 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 8.921842e-01 | 0.050 | 0 | 0 |
| Proton-coupled monocarboxylate transport | R-HSA-433692 | 8.921842e-01 | 0.050 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 8.921842e-01 | 0.050 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 8.921842e-01 | 0.050 | 0 | 0 |
| Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB | R-HSA-141333 | 8.921842e-01 | 0.050 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 8.921842e-01 | 0.050 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 8.921842e-01 | 0.050 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 8.942609e-01 | 0.049 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 8.942609e-01 | 0.049 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 8.977086e-01 | 0.047 | 0 | 0 |
| Matriglycan biosynthesis on DAG1 | R-HSA-9939291 | 8.977086e-01 | 0.047 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 8.977086e-01 | 0.047 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 9.002023e-01 | 0.046 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.002023e-01 | 0.046 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 9.016828e-01 | 0.045 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 9.035522e-01 | 0.044 | 0 | 0 |
| Defective EXT1 causes exostoses 1, TRPS2 and CHDS | R-HSA-3656253 | 9.070686e-01 | 0.042 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 9.070686e-01 | 0.042 | 0 | 0 |
| Defective EXT2 causes exostoses 2 | R-HSA-3656237 | 9.070686e-01 | 0.042 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 9.070686e-01 | 0.042 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 9.070686e-01 | 0.042 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 9.070686e-01 | 0.042 | 0 | 0 |
| Proline catabolism | R-HSA-70688 | 9.070686e-01 | 0.042 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 9.070686e-01 | 0.042 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 9.070686e-01 | 0.042 | 0 | 0 |
| Synthesis of GDP-mannose | R-HSA-446205 | 9.070686e-01 | 0.042 | 0 | 0 |
| Estrogen biosynthesis | R-HSA-193144 | 9.070686e-01 | 0.042 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 9.070686e-01 | 0.042 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 9.087584e-01 | 0.042 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.090900e-01 | 0.041 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 9.090900e-01 | 0.041 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 9.091409e-01 | 0.041 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 9.091409e-01 | 0.041 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 9.097062e-01 | 0.041 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.097971e-01 | 0.041 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.113475e-01 | 0.040 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.132078e-01 | 0.039 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 9.172668e-01 | 0.038 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 9.172668e-01 | 0.038 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 9.172668e-01 | 0.038 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 9.193672e-01 | 0.037 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 9.193672e-01 | 0.037 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 9.193672e-01 | 0.037 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy | R-HSA-9857377 | 9.193672e-01 | 0.037 | 0 | 0 |
| OGDH complex synthesizes succinyl-CoA from 2-OG | R-HSA-9853506 | 9.198989e-01 | 0.036 | 0 | 0 |
| PDH complex synthesizes acetyl-CoA from PYR | R-HSA-9861559 | 9.198989e-01 | 0.036 | 0 | 0 |
| FGFR2c ligand binding and activation | R-HSA-190375 | 9.198989e-01 | 0.036 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 9.198989e-01 | 0.036 | 0 | 0 |
| FGFR4 ligand binding and activation | R-HSA-190322 | 9.198989e-01 | 0.036 | 0 | 0 |
| Signaling by activated point mutants of FGFR3 | R-HSA-1839130 | 9.198989e-01 | 0.036 | 0 | 0 |
| FGFR3 mutant receptor activation | R-HSA-2033514 | 9.198989e-01 | 0.036 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 9.198989e-01 | 0.036 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 9.201408e-01 | 0.036 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 9.240501e-01 | 0.034 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.240501e-01 | 0.034 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 9.247791e-01 | 0.034 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.247791e-01 | 0.034 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.251902e-01 | 0.034 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.272236e-01 | 0.033 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 9.281297e-01 | 0.032 | 0 | 0 |
| FGFR3c ligand binding and activation | R-HSA-190372 | 9.309584e-01 | 0.031 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 9.309584e-01 | 0.031 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 9.309584e-01 | 0.031 | 0 | 0 |
| N-glycan trimming and elongation in the cis-Golgi | R-HSA-964739 | 9.309584e-01 | 0.031 | 0 | 0 |
| Formation of the active cofactor, UDP-glucuronate | R-HSA-173599 | 9.309584e-01 | 0.031 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 9.309584e-01 | 0.031 | 0 | 0 |
| P2Y receptors | R-HSA-417957 | 9.309584e-01 | 0.031 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 9.309584e-01 | 0.031 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 9.309584e-01 | 0.031 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.353779e-01 | 0.029 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.353779e-01 | 0.029 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 9.366529e-01 | 0.028 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 9.366529e-01 | 0.028 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 9.366529e-01 | 0.028 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 9.366529e-01 | 0.028 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.366529e-01 | 0.028 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 9.404915e-01 | 0.027 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 9.404915e-01 | 0.027 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 9.404915e-01 | 0.027 | 0 | 0 |
| Protein lipoylation | R-HSA-9857492 | 9.404915e-01 | 0.027 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 9.404915e-01 | 0.027 | 0 | 0 |
| FGFR3 ligand binding and activation | R-HSA-190239 | 9.404915e-01 | 0.027 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 9.404915e-01 | 0.027 | 0 | 0 |
| Dopamine clearance from the synaptic cleft | R-HSA-379401 | 9.404915e-01 | 0.027 | 0 | 0 |
| FASTK family proteins regulate processing and stability of mitochondrial RNAs | R-HSA-9837092 | 9.404915e-01 | 0.027 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 9.404915e-01 | 0.027 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 9.409570e-01 | 0.026 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.418743e-01 | 0.026 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 9.419457e-01 | 0.026 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 9.419457e-01 | 0.026 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.419457e-01 | 0.026 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 9.419457e-01 | 0.026 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 9.426055e-01 | 0.026 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.436507e-01 | 0.025 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 9.439164e-01 | 0.025 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.456193e-01 | 0.024 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.460462e-01 | 0.024 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.471311e-01 | 0.024 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.478895e-01 | 0.023 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.478895e-01 | 0.023 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.485991e-01 | 0.023 | 1 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 9.487088e-01 | 0.023 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 9.487088e-01 | 0.023 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 9.487088e-01 | 0.023 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 9.487088e-01 | 0.023 | 0 | 0 |
| Serotonin and melatonin biosynthesis | R-HSA-209931 | 9.487088e-01 | 0.023 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 9.487088e-01 | 0.023 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 9.487088e-01 | 0.023 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 9.487088e-01 | 0.023 | 0 | 0 |
| Virus Assembly and Release | R-HSA-168268 | 9.487088e-01 | 0.023 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.503823e-01 | 0.022 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 9.503823e-01 | 0.022 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 9.503823e-01 | 0.022 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 9.512481e-01 | 0.022 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.532624e-01 | 0.021 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 9.557918e-01 | 0.020 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 9.557918e-01 | 0.020 | 0 | 0 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | R-HSA-4420332 | 9.557918e-01 | 0.020 | 0 | 0 |
| Defective B4GALT7 causes EDS, progeroid type | R-HSA-3560783 | 9.557918e-01 | 0.020 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 9.557918e-01 | 0.020 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 9.557918e-01 | 0.020 | 0 | 0 |
| Biosynthesis of maresin-like SPMs | R-HSA-9027307 | 9.557918e-01 | 0.020 | 0 | 0 |
| Heme assimilation | R-HSA-9927020 | 9.557918e-01 | 0.020 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 9.557918e-01 | 0.020 | 0 | 0 |
| Formation of xylulose-5-phosphate | R-HSA-5661270 | 9.557918e-01 | 0.020 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 9.561324e-01 | 0.019 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 9.561324e-01 | 0.019 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 9.561324e-01 | 0.019 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 9.561324e-01 | 0.019 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 9.581138e-01 | 0.019 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.582759e-01 | 0.019 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.582759e-01 | 0.019 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 9.612411e-01 | 0.017 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 9.618970e-01 | 0.017 | 0 | 0 |
| Defective B3GAT3 causes JDSSDHD | R-HSA-3560801 | 9.618970e-01 | 0.017 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 9.618970e-01 | 0.017 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 9.618970e-01 | 0.017 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.624092e-01 | 0.017 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.624896e-01 | 0.017 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 9.657758e-01 | 0.015 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.659338e-01 | 0.015 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.664324e-01 | 0.015 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.668867e-01 | 0.015 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 9.671594e-01 | 0.015 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 9.671594e-01 | 0.015 | 0 | 0 |
| Activated point mutants of FGFR2 | R-HSA-2033519 | 9.671594e-01 | 0.015 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 9.671594e-01 | 0.015 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 9.671594e-01 | 0.015 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 9.671594e-01 | 0.015 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.681729e-01 | 0.014 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 9.697975e-01 | 0.013 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.699138e-01 | 0.013 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.699138e-01 | 0.013 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.706126e-01 | 0.013 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 9.716953e-01 | 0.012 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 9.716953e-01 | 0.012 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 9.716953e-01 | 0.012 | 0 | 0 |
| Amine Oxidase reactions | R-HSA-140179 | 9.716953e-01 | 0.012 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.722655e-01 | 0.012 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.726798e-01 | 0.012 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.726798e-01 | 0.012 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 9.731735e-01 | 0.012 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.731735e-01 | 0.012 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 9.733615e-01 | 0.012 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.733615e-01 | 0.012 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 9.756049e-01 | 0.011 | 0 | 0 |
| Mitochondrial iron-sulfur cluster biogenesis | R-HSA-1362409 | 9.756049e-01 | 0.011 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.756049e-01 | 0.011 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 9.756049e-01 | 0.011 | 0 | 0 |
| Synthesis of Ketone Bodies | R-HSA-77111 | 9.756049e-01 | 0.011 | 0 | 0 |
| DAG1 glycosylations | R-HSA-8931838 | 9.765174e-01 | 0.010 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 9.765174e-01 | 0.010 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.775167e-01 | 0.010 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 9.786164e-01 | 0.009 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 9.786164e-01 | 0.009 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 9.786164e-01 | 0.009 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 9.789747e-01 | 0.009 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 9.789747e-01 | 0.009 | 0 | 0 |
| FGFR2 ligand binding and activation | R-HSA-190241 | 9.789747e-01 | 0.009 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 9.789747e-01 | 0.009 | 0 | 0 |
| Abacavir metabolism | R-HSA-2161541 | 9.789747e-01 | 0.009 | 0 | 0 |
| Defective B3GALTL causes PpS | R-HSA-5083635 | 9.793100e-01 | 0.009 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 9.793100e-01 | 0.009 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.801590e-01 | 0.009 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.816554e-01 | 0.008 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.817794e-01 | 0.008 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 9.818791e-01 | 0.008 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.818791e-01 | 0.008 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 9.818791e-01 | 0.008 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 9.818791e-01 | 0.008 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.836030e-01 | 0.007 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 9.839615e-01 | 0.007 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 9.843825e-01 | 0.007 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 9.843825e-01 | 0.007 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.843825e-01 | 0.007 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.845207e-01 | 0.007 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 9.848501e-01 | 0.007 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 9.848501e-01 | 0.007 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.852661e-01 | 0.006 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.860246e-01 | 0.006 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.860246e-01 | 0.006 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.863355e-01 | 0.006 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 9.865402e-01 | 0.006 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.865402e-01 | 0.006 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 9.865402e-01 | 0.006 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 9.865402e-01 | 0.006 | 0 | 0 |
| Ketone body metabolism | R-HSA-74182 | 9.865402e-01 | 0.006 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 9.865402e-01 | 0.006 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 9.865402e-01 | 0.006 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 9.875895e-01 | 0.005 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 9.875895e-01 | 0.005 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.879071e-01 | 0.005 | 0 | 0 |
| CYP2E1 reactions | R-HSA-211999 | 9.883999e-01 | 0.005 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 9.883999e-01 | 0.005 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 9.883999e-01 | 0.005 | 0 | 0 |
| O-glycosylation of TSR domain-containing proteins | R-HSA-5173214 | 9.890899e-01 | 0.005 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 9.890899e-01 | 0.005 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.890899e-01 | 0.005 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.890899e-01 | 0.005 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.890899e-01 | 0.005 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.890899e-01 | 0.005 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.893196e-01 | 0.005 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.893461e-01 | 0.005 | 0 | 0 |
| Alpha-oxidation of phytanate | R-HSA-389599 | 9.900027e-01 | 0.004 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 9.900027e-01 | 0.004 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 9.900027e-01 | 0.004 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.900027e-01 | 0.004 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.900027e-01 | 0.004 | 0 | 0 |
| tRNA processing in the mitochondrion | R-HSA-6785470 | 9.904127e-01 | 0.004 | 0 | 0 |
| Depurination | R-HSA-73927 | 9.904127e-01 | 0.004 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.904127e-01 | 0.004 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.904478e-01 | 0.004 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.905040e-01 | 0.004 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.908952e-01 | 0.004 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.909192e-01 | 0.004 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.913015e-01 | 0.004 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.913841e-01 | 0.004 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 9.913841e-01 | 0.004 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.913841e-01 | 0.004 | 0 | 0 |
| Linoleic acid (LA) metabolism | R-HSA-2046105 | 9.913841e-01 | 0.004 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 9.913841e-01 | 0.004 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.913841e-01 | 0.004 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.915784e-01 | 0.004 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.920315e-01 | 0.003 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.925748e-01 | 0.003 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.925748e-01 | 0.003 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.925748e-01 | 0.003 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 9.925748e-01 | 0.003 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.925748e-01 | 0.003 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.926051e-01 | 0.003 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.936009e-01 | 0.003 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 9.936009e-01 | 0.003 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.938584e-01 | 0.003 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.940273e-01 | 0.003 | 1 | 0 |
| Collagen formation | R-HSA-1474290 | 9.943346e-01 | 0.002 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 9.944853e-01 | 0.002 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.947610e-01 | 0.002 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.950037e-01 | 0.002 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.950037e-01 | 0.002 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.950037e-01 | 0.002 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.952475e-01 | 0.002 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.952776e-01 | 0.002 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.956121e-01 | 0.002 | 0 | 0 |
| Synthesis of very long-chain fatty acyl-CoAs | R-HSA-75876 | 9.956187e-01 | 0.002 | 0 | 0 |
| Synthesis of glycosylphosphatidylinositol (GPI) | R-HSA-162710 | 9.959044e-01 | 0.002 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.960809e-01 | 0.002 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.961592e-01 | 0.002 | 0 | 0 |
| HS-GAG degradation | R-HSA-2024096 | 9.964705e-01 | 0.002 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.968428e-01 | 0.001 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.968775e-01 | 0.001 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.968805e-01 | 0.001 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.969584e-01 | 0.001 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.970460e-01 | 0.001 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.970510e-01 | 0.001 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.971323e-01 | 0.001 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.972145e-01 | 0.001 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 9.977413e-01 | 0.001 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.977413e-01 | 0.001 | 0 | 0 |
| Phosphate bond hydrolysis by NUDT proteins | R-HSA-2393930 | 9.977413e-01 | 0.001 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.980274e-01 | 0.001 | 0 | 0 |
| Synthesis of bile acids and bile salts via 24-hydroxycholesterol | R-HSA-193775 | 9.980536e-01 | 0.001 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.982431e-01 | 0.001 | 0 | 0 |
| Translation | R-HSA-72766 | 9.982532e-01 | 0.001 | 0 | 0 |
| HS-GAG biosynthesis | R-HSA-2022928 | 9.983227e-01 | 0.001 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.983762e-01 | 0.001 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.984838e-01 | 0.001 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.985118e-01 | 0.001 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.985237e-01 | 0.001 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.985324e-01 | 0.001 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.985546e-01 | 0.001 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.986690e-01 | 0.001 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 9.987545e-01 | 0.001 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.987613e-01 | 0.001 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.989343e-01 | 0.000 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.990752e-01 | 0.000 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 9.990752e-01 | 0.000 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.990752e-01 | 0.000 | 0 | 0 |
| Aflatoxin activation and detoxification | R-HSA-5423646 | 9.992031e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.992680e-01 | 0.000 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.993133e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.993133e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.993291e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.993543e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.993543e-01 | 0.000 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 9.994902e-01 | 0.000 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.995175e-01 | 0.000 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.995489e-01 | 0.000 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.995489e-01 | 0.000 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.995489e-01 | 0.000 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.995607e-01 | 0.000 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.996061e-01 | 0.000 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.996061e-01 | 0.000 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.996061e-01 | 0.000 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.996215e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.996985e-01 | 0.000 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 9.997190e-01 | 0.000 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.997190e-01 | 0.000 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.997341e-01 | 0.000 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.997381e-01 | 0.000 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.997579e-01 | 0.000 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 9.997600e-01 | 0.000 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.997660e-01 | 0.000 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.997914e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.998189e-01 | 0.000 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.998202e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.998262e-01 | 0.000 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.998451e-01 | 0.000 | 0 | 0 |
| Cytosolic sulfonation of small molecules | R-HSA-156584 | 9.998451e-01 | 0.000 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.998451e-01 | 0.000 | 0 | 0 |
| Scavenging of heme from plasma | R-HSA-2168880 | 9.998879e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.998949e-01 | 0.000 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.998996e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999008e-01 | 0.000 | 0 | 0 |
| Glucuronidation | R-HSA-156588 | 9.999009e-01 | 0.000 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.999165e-01 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.999180e-01 | 0.000 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.999237e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999259e-01 | 0.000 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.999265e-01 | 0.000 | 0 | 0 |
| Classical antibody-mediated complement activation | R-HSA-173623 | 9.999356e-01 | 0.000 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.999366e-01 | 0.000 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.999366e-01 | 0.000 | 0 | 0 |
| Heparan sulfate/heparin (HS-GAG) metabolism | R-HSA-1638091 | 9.999530e-01 | 0.000 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.999595e-01 | 0.000 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.999741e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.999770e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999841e-01 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.999851e-01 | 0.000 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.999857e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999866e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.999877e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.999904e-01 | 0.000 | 0 | 0 |
| Metal ion assimilation from the host | R-HSA-9638482 | 9.999921e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999931e-01 | 0.000 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.999932e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.999932e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.999947e-01 | 0.000 | 0 | 0 |
| Creation of C4 and C2 activators | R-HSA-166786 | 9.999960e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999968e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.999968e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.999972e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999973e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.999976e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999979e-01 | 0.000 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.999982e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.999983e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999985e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999986e-01 | 0.000 | 0 | 0 |
| Initial triggering of complement | R-HSA-166663 | 9.999988e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.999989e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999992e-01 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 9.999995e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999996e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.999996e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999996e-01 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.999997e-01 | 0.000 | 1 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999997e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999998e-01 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.999998e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999999e-01 | 0.000 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.999999e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.999999e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 1.000000e+00 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 1.000000e+00 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 1.000000e+00 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Gene expression (Transcription) | R-HSA-74160 | 1.587619e-14 | 13.799 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 4.897527e-12 | 11.310 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 7.583723e-11 | 10.120 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 9.251591e-09 | 8.034 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 7.972801e-09 | 8.098 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.048351e-08 | 7.979 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 4.878280e-07 | 6.312 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 4.919352e-07 | 6.308 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 6.680427e-07 | 6.175 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 1.407037e-06 | 5.852 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 2.423524e-06 | 5.616 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 2.580157e-06 | 5.588 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 4.787160e-06 | 5.320 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 4.656595e-06 | 5.332 | 1 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 5.587021e-06 | 5.253 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 5.490791e-06 | 5.260 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 6.445360e-06 | 5.191 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 1.017567e-05 | 4.992 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 1.017567e-05 | 4.992 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 1.034143e-05 | 4.985 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 1.234838e-05 | 4.908 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 1.415811e-05 | 4.849 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.438371e-05 | 4.842 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.374618e-05 | 4.862 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 1.378589e-05 | 4.861 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 1.704517e-05 | 4.768 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 2.151270e-05 | 4.667 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 2.271134e-05 | 4.644 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 2.854437e-05 | 4.544 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 2.747224e-05 | 4.561 | 1 | 1 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 3.819545e-05 | 4.418 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 3.819545e-05 | 4.418 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 3.896661e-05 | 4.409 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 3.864026e-05 | 4.413 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 4.191672e-05 | 4.378 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 4.186278e-05 | 4.378 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 4.597939e-05 | 4.337 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 4.994079e-05 | 4.302 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 5.150666e-05 | 4.288 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 6.004981e-05 | 4.221 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 6.030606e-05 | 4.220 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 6.636919e-05 | 4.178 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 7.799683e-05 | 4.108 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 8.627302e-05 | 4.064 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 8.960257e-05 | 4.048 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 9.019475e-05 | 4.045 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 9.597878e-05 | 4.018 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 1.060281e-04 | 3.975 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 1.032125e-04 | 3.986 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 1.060281e-04 | 3.975 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 1.111749e-04 | 3.954 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 1.124412e-04 | 3.949 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.516459e-04 | 3.819 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.519375e-04 | 3.818 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.733889e-04 | 3.761 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 1.801607e-04 | 3.744 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 2.105419e-04 | 3.677 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 2.267314e-04 | 3.644 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 2.833005e-04 | 3.548 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 3.222029e-04 | 3.492 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 3.515651e-04 | 3.454 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 3.683848e-04 | 3.434 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 3.683848e-04 | 3.434 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 3.679407e-04 | 3.434 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 3.951342e-04 | 3.403 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 4.125441e-04 | 3.385 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 4.132650e-04 | 3.384 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 4.193531e-04 | 3.377 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 4.219669e-04 | 3.375 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 4.139930e-04 | 3.383 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 4.334273e-04 | 3.363 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 4.360766e-04 | 3.360 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 4.817941e-04 | 3.317 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 5.310073e-04 | 3.275 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 5.310073e-04 | 3.275 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 5.387932e-04 | 3.269 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 5.617029e-04 | 3.250 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 6.006855e-04 | 3.221 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 6.088574e-04 | 3.215 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 6.366357e-04 | 3.196 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 6.806703e-04 | 3.167 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 7.017849e-04 | 3.154 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 7.349874e-04 | 3.134 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 7.559999e-04 | 3.121 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 7.644168e-04 | 3.117 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 8.167644e-04 | 3.088 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 8.210959e-04 | 3.086 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 8.068194e-04 | 3.093 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 8.210959e-04 | 3.086 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 8.986492e-04 | 3.046 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 8.578162e-04 | 3.067 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 8.301829e-04 | 3.081 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 9.326936e-04 | 3.030 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 8.986492e-04 | 3.046 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 9.463668e-04 | 3.024 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 9.592983e-04 | 3.018 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 9.969953e-04 | 3.001 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 1.040404e-03 | 2.983 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 1.085984e-03 | 2.964 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.119549e-03 | 2.951 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.132206e-03 | 2.946 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 1.227255e-03 | 2.911 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 1.248470e-03 | 2.904 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 1.248470e-03 | 2.904 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 1.348786e-03 | 2.870 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 1.325710e-03 | 2.878 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 1.345492e-03 | 2.871 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 1.386382e-03 | 2.858 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 1.497390e-03 | 2.825 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 1.497390e-03 | 2.825 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 1.505564e-03 | 2.822 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 1.533362e-03 | 2.814 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 1.595423e-03 | 2.797 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 1.611355e-03 | 2.793 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 1.767896e-03 | 2.753 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 1.767896e-03 | 2.753 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 1.656557e-03 | 2.781 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 1.841262e-03 | 2.735 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.878010e-03 | 2.726 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 2.061873e-03 | 2.686 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 2.076755e-03 | 2.683 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 2.096971e-03 | 2.678 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 2.096971e-03 | 2.678 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 2.142383e-03 | 2.669 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 2.142383e-03 | 2.669 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 2.212067e-03 | 2.655 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 2.444054e-03 | 2.612 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 2.507915e-03 | 2.601 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 2.344445e-03 | 2.630 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 2.676965e-03 | 2.572 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 2.870672e-03 | 2.542 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 3.162738e-03 | 2.500 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 3.268930e-03 | 2.486 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 3.326918e-03 | 2.478 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 3.344099e-03 | 2.476 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 3.526525e-03 | 2.453 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 3.526850e-03 | 2.453 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 3.743135e-03 | 2.427 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 3.743135e-03 | 2.427 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 3.743135e-03 | 2.427 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 4.133940e-03 | 2.384 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 4.182885e-03 | 2.379 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 4.347572e-03 | 2.362 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 4.347572e-03 | 2.362 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 4.431856e-03 | 2.353 | 1 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 4.466786e-03 | 2.350 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 4.751764e-03 | 2.323 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 4.753240e-03 | 2.323 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 4.947221e-03 | 2.306 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 5.023947e-03 | 2.299 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 5.159610e-03 | 2.287 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 5.455748e-03 | 2.263 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 5.622088e-03 | 2.250 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 6.036292e-03 | 2.219 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 6.036292e-03 | 2.219 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 6.324531e-03 | 2.199 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 6.200229e-03 | 2.208 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 6.324531e-03 | 2.199 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 6.089554e-03 | 2.215 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 6.435151e-03 | 2.191 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 6.641937e-03 | 2.178 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 6.718381e-03 | 2.173 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 7.073744e-03 | 2.150 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 7.506982e-03 | 2.125 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 7.551623e-03 | 2.122 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 7.575064e-03 | 2.121 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 8.234887e-03 | 2.084 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 9.517134e-03 | 2.021 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 9.517134e-03 | 2.021 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 9.517134e-03 | 2.021 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 8.514317e-03 | 2.070 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 8.981967e-03 | 2.047 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 8.902102e-03 | 2.051 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 9.573324e-03 | 2.019 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 9.573324e-03 | 2.019 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 9.573324e-03 | 2.019 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 9.404417e-03 | 2.027 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 1.003873e-02 | 1.998 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 1.047971e-02 | 1.980 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 1.125947e-02 | 1.948 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 1.103561e-02 | 1.957 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 1.128613e-02 | 1.947 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 1.128613e-02 | 1.947 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 1.128613e-02 | 1.947 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 1.128613e-02 | 1.947 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 1.128613e-02 | 1.947 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 1.147859e-02 | 1.940 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 1.158066e-02 | 1.936 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 1.066098e-02 | 1.972 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.202738e-02 | 1.920 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 1.068462e-02 | 1.971 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 1.063986e-02 | 1.973 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 1.056928e-02 | 1.976 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 1.204676e-02 | 1.919 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 1.204676e-02 | 1.919 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 1.239997e-02 | 1.907 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.241134e-02 | 1.906 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 1.261862e-02 | 1.899 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 1.268415e-02 | 1.897 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 1.404353e-02 | 1.853 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 1.404353e-02 | 1.853 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.404353e-02 | 1.853 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 1.515934e-02 | 1.819 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 1.515934e-02 | 1.819 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 1.515934e-02 | 1.819 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 1.515934e-02 | 1.819 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 1.562709e-02 | 1.806 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 1.799972e-02 | 1.745 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 1.799972e-02 | 1.745 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 1.832943e-02 | 1.737 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 1.572909e-02 | 1.803 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 1.615223e-02 | 1.792 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 1.646947e-02 | 1.783 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.727049e-02 | 1.763 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 1.572909e-02 | 1.803 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 1.633458e-02 | 1.787 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 1.595520e-02 | 1.797 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.725048e-02 | 1.763 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 1.957787e-02 | 1.708 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 1.957787e-02 | 1.708 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 1.986495e-02 | 1.702 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 1.986495e-02 | 1.702 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 2.121037e-02 | 1.673 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 2.121037e-02 | 1.673 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 2.193408e-02 | 1.659 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 2.193408e-02 | 1.659 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 2.193792e-02 | 1.659 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 2.208839e-02 | 1.656 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 2.231710e-02 | 1.651 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 2.233322e-02 | 1.651 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 2.382618e-02 | 1.623 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 2.397048e-02 | 1.620 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 2.402394e-02 | 1.619 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 2.431889e-02 | 1.614 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 2.493613e-02 | 1.603 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 2.566653e-02 | 1.591 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 2.635980e-02 | 1.579 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 2.638875e-02 | 1.579 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 2.675824e-02 | 1.573 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 2.690517e-02 | 1.570 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 2.690517e-02 | 1.570 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 3.115349e-02 | 1.506 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 3.115349e-02 | 1.506 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 3.172582e-02 | 1.499 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 3.061074e-02 | 1.514 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 3.061074e-02 | 1.514 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 3.061074e-02 | 1.514 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 3.018077e-02 | 1.520 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 3.245366e-02 | 1.489 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 3.172582e-02 | 1.499 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 2.794503e-02 | 1.554 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 2.887171e-02 | 1.540 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 3.172582e-02 | 1.499 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 3.287923e-02 | 1.483 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 3.292990e-02 | 1.482 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 3.405433e-02 | 1.468 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 3.412280e-02 | 1.467 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 3.434168e-02 | 1.464 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 3.438316e-02 | 1.464 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 3.438316e-02 | 1.464 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 3.526213e-02 | 1.453 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 3.526213e-02 | 1.453 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 3.537222e-02 | 1.451 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 3.537222e-02 | 1.451 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 3.537222e-02 | 1.451 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 3.537222e-02 | 1.451 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 3.568892e-02 | 1.447 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 3.687876e-02 | 1.433 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 3.772008e-02 | 1.423 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 3.772008e-02 | 1.423 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 3.772008e-02 | 1.423 | 1 | 0 |
| IKBKB deficiency causes SCID | R-HSA-5602636 | 3.790808e-02 | 1.421 | 0 | 0 |
| IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) | R-HSA-5603027 | 3.790808e-02 | 1.421 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 3.826242e-02 | 1.417 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 3.826242e-02 | 1.417 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 3.829443e-02 | 1.417 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 3.837860e-02 | 1.416 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 4.049765e-02 | 1.393 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 4.088870e-02 | 1.388 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 4.123282e-02 | 1.385 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 4.123282e-02 | 1.385 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 4.123282e-02 | 1.385 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 4.174871e-02 | 1.379 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 4.174871e-02 | 1.379 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 4.908727e-02 | 1.309 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 4.628524e-02 | 1.335 | 1 | 1 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 4.628524e-02 | 1.335 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 4.628524e-02 | 1.335 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 5.523415e-02 | 1.258 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 4.439174e-02 | 1.353 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 5.405575e-02 | 1.267 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 4.740821e-02 | 1.324 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 5.062568e-02 | 1.296 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 5.303200e-02 | 1.275 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 5.372061e-02 | 1.270 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 5.421044e-02 | 1.266 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 4.842502e-02 | 1.315 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 5.448909e-02 | 1.264 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 4.842502e-02 | 1.315 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 4.922757e-02 | 1.308 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 5.393943e-02 | 1.268 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 5.393943e-02 | 1.268 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 4.439174e-02 | 1.353 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 4.842502e-02 | 1.315 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 4.423219e-02 | 1.354 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 4.628524e-02 | 1.335 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 5.303200e-02 | 1.275 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 4.842502e-02 | 1.315 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 5.175572e-02 | 1.286 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 5.094842e-02 | 1.293 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 5.599704e-02 | 1.252 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 5.773524e-02 | 1.239 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 5.776557e-02 | 1.238 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 5.932702e-02 | 1.227 | 1 | 1 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 5.982154e-02 | 1.223 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 6.036077e-02 | 1.219 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 6.036077e-02 | 1.219 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 6.101739e-02 | 1.215 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 6.130464e-02 | 1.213 | 0 | 0 |
| Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization | R-HSA-180897 | 6.311740e-02 | 1.200 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 6.500478e-02 | 1.187 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 6.511150e-02 | 1.186 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 6.511150e-02 | 1.186 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 6.511150e-02 | 1.186 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 6.511150e-02 | 1.186 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 6.599262e-02 | 1.181 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 6.780358e-02 | 1.169 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 6.795793e-02 | 1.168 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 6.801549e-02 | 1.167 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 6.835547e-02 | 1.165 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 6.835547e-02 | 1.165 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 6.835547e-02 | 1.165 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 6.835547e-02 | 1.165 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 6.859338e-02 | 1.164 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 6.859338e-02 | 1.164 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 6.911975e-02 | 1.160 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 6.924389e-02 | 1.160 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 7.058653e-02 | 1.151 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 7.470236e-02 | 1.127 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 7.548672e-02 | 1.122 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 7.591028e-02 | 1.120 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 7.591028e-02 | 1.120 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 9.649617e-02 | 1.015 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 9.649617e-02 | 1.015 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 9.649617e-02 | 1.015 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 9.242048e-02 | 1.034 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 9.242048e-02 | 1.034 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 9.242048e-02 | 1.034 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 8.297127e-02 | 1.081 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 8.297127e-02 | 1.081 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 1.028039e-01 | 0.988 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 1.028039e-01 | 0.988 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 8.199618e-02 | 1.086 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 9.686509e-02 | 1.014 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 9.686509e-02 | 1.014 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 9.686509e-02 | 1.014 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 9.686509e-02 | 1.014 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 1.002005e-01 | 0.999 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 7.750292e-02 | 1.111 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 8.974642e-02 | 1.047 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 9.720532e-02 | 1.012 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 9.840921e-02 | 1.007 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 9.686509e-02 | 1.014 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 8.199618e-02 | 1.086 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 9.596430e-02 | 1.018 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 9.910834e-02 | 1.004 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 9.140717e-02 | 1.039 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 8.441097e-02 | 1.074 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 9.739223e-02 | 1.011 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 8.824548e-02 | 1.054 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 7.979982e-02 | 1.098 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 7.910347e-02 | 1.102 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 9.686509e-02 | 1.014 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 8.449857e-02 | 1.073 | 0 | 0 |
| Inhibition of nitric oxide production | R-HSA-9636249 | 9.242048e-02 | 1.034 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 9.523138e-02 | 1.021 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 1.007390e-01 | 0.997 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 1.035535e-01 | 0.985 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.035535e-01 | 0.985 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 1.100914e-01 | 0.958 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 1.106429e-01 | 0.956 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 1.106429e-01 | 0.956 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 1.106429e-01 | 0.956 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 1.128949e-01 | 0.947 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 1.128949e-01 | 0.947 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 1.128949e-01 | 0.947 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 1.128949e-01 | 0.947 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.128949e-01 | 0.947 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.131932e-01 | 0.946 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.131932e-01 | 0.946 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 1.136365e-01 | 0.944 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 1.136365e-01 | 0.944 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 1.166389e-01 | 0.933 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 1.200696e-01 | 0.921 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 1.200696e-01 | 0.921 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 1.228291e-01 | 0.911 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.230073e-01 | 0.910 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 1.236812e-01 | 0.908 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 1.243013e-01 | 0.906 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 1.243013e-01 | 0.906 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 1.243013e-01 | 0.906 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 1.243013e-01 | 0.906 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 1.243013e-01 | 0.906 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 1.243013e-01 | 0.906 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 1.243013e-01 | 0.906 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 1.243013e-01 | 0.906 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 1.243013e-01 | 0.906 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 1.247935e-01 | 0.904 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 1.247935e-01 | 0.904 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 1.247935e-01 | 0.904 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 1.247935e-01 | 0.904 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 1.247935e-01 | 0.904 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 1.254463e-01 | 0.902 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.258420e-01 | 0.900 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 1.277774e-01 | 0.894 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 1.277774e-01 | 0.894 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 1.277774e-01 | 0.894 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 1.278847e-01 | 0.893 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 1.278847e-01 | 0.893 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 1.278847e-01 | 0.893 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 1.300075e-01 | 0.886 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 1.300075e-01 | 0.886 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 1.300075e-01 | 0.886 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 1.300075e-01 | 0.886 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 1.301564e-01 | 0.886 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.836860e-01 | 0.736 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.836860e-01 | 0.736 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.836860e-01 | 0.736 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.836860e-01 | 0.736 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.836860e-01 | 0.736 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 1.593720e-01 | 0.798 | 0 | 0 |
| IRS activation | R-HSA-74713 | 1.593720e-01 | 0.798 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 1.593720e-01 | 0.798 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 1.593720e-01 | 0.798 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 1.954295e-01 | 0.709 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 1.954295e-01 | 0.709 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 1.954295e-01 | 0.709 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 1.714420e-01 | 0.766 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 1.714420e-01 | 0.766 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 1.481163e-01 | 0.829 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 1.671286e-01 | 0.777 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 1.356427e-01 | 0.868 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 1.356427e-01 | 0.868 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 1.750421e-01 | 0.757 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 1.920577e-01 | 0.717 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 1.920577e-01 | 0.717 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.380338e-01 | 0.860 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 1.876743e-01 | 0.727 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 1.725880e-01 | 0.763 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.590802e-01 | 0.798 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 1.868982e-01 | 0.728 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 1.868982e-01 | 0.728 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 1.868982e-01 | 0.728 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 1.481163e-01 | 0.829 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 1.671286e-01 | 0.777 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 1.796714e-01 | 0.746 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 1.481163e-01 | 0.829 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 1.907594e-01 | 0.720 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 1.920577e-01 | 0.717 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 1.730580e-01 | 0.762 | 0 | 0 |
| Formation of lateral plate mesoderm | R-HSA-9758920 | 1.954295e-01 | 0.709 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 1.838736e-01 | 0.735 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 1.752558e-01 | 0.756 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 1.954295e-01 | 0.709 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.736470e-01 | 0.760 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 1.481163e-01 | 0.829 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 1.616342e-01 | 0.791 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 1.305772e-01 | 0.884 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 1.408477e-01 | 0.851 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 1.349372e-01 | 0.870 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 1.472521e-01 | 0.832 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 1.698961e-01 | 0.770 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 1.836860e-01 | 0.736 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 1.593720e-01 | 0.798 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 1.472521e-01 | 0.832 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 1.671286e-01 | 0.777 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 1.429014e-01 | 0.845 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 1.641948e-01 | 0.785 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 1.303269e-01 | 0.885 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 1.478256e-01 | 0.830 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 1.750421e-01 | 0.757 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in invasion | R-HSA-9854909 | 1.593720e-01 | 0.798 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 1.472521e-01 | 0.832 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.568567e-01 | 0.804 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 1.593720e-01 | 0.798 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.634812e-01 | 0.787 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 1.907594e-01 | 0.720 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 1.593720e-01 | 0.798 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 1.954295e-01 | 0.709 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 1.650570e-01 | 0.782 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 1.966586e-01 | 0.706 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 1.999374e-01 | 0.699 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 2.038695e-01 | 0.691 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 2.046529e-01 | 0.689 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 2.046529e-01 | 0.689 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 2.046529e-01 | 0.689 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 2.046529e-01 | 0.689 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 2.059833e-01 | 0.686 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 2.073813e-01 | 0.683 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 2.073813e-01 | 0.683 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 2.074721e-01 | 0.683 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 2.080517e-01 | 0.682 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 2.095056e-01 | 0.679 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 2.168673e-01 | 0.664 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 2.182904e-01 | 0.661 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 2.226959e-01 | 0.652 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 2.226959e-01 | 0.652 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 2.226959e-01 | 0.652 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 2.226959e-01 | 0.652 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 2.239514e-01 | 0.650 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 2.265557e-01 | 0.645 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 2.265557e-01 | 0.645 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 2.265557e-01 | 0.645 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 2.276606e-01 | 0.643 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 2.276606e-01 | 0.643 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 2.276884e-01 | 0.643 | 0 | 0 |
| NFG and proNGF binds to p75NTR | R-HSA-205017 | 2.624664e-01 | 0.581 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 2.624664e-01 | 0.581 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 2.624664e-01 | 0.581 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 2.624664e-01 | 0.581 | 0 | 0 |
| Defective SLC12A3 causes Gitelman syndrome (GS) | R-HSA-5619087 | 2.624664e-01 | 0.581 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 2.624664e-01 | 0.581 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 3.336482e-01 | 0.477 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 3.336482e-01 | 0.477 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 3.336482e-01 | 0.477 | 0 | 0 |
| Signalling to ERK5 | R-HSA-198765 | 3.336482e-01 | 0.477 | 0 | 0 |
| TGFBR3 regulates activin signaling | R-HSA-9839406 | 3.336482e-01 | 0.477 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 3.336482e-01 | 0.477 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 3.336482e-01 | 0.477 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 3.336482e-01 | 0.477 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 3.336482e-01 | 0.477 | 0 | 0 |
| Defective SLC12A1 causes Bartter syndrome 1 (BS1) | R-HSA-5619104 | 3.336482e-01 | 0.477 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 3.336482e-01 | 0.477 | 0 | 0 |
| Defective ALG14 causes ALG14-CMS | R-HSA-5633231 | 3.336482e-01 | 0.477 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 3.336482e-01 | 0.477 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 3.336482e-01 | 0.477 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 3.336482e-01 | 0.477 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 3.336482e-01 | 0.477 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 2.323590e-01 | 0.634 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 2.323590e-01 | 0.634 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 2.696570e-01 | 0.569 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 2.696570e-01 | 0.569 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 2.696570e-01 | 0.569 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 2.696570e-01 | 0.569 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 2.696570e-01 | 0.569 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 2.696570e-01 | 0.569 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis | R-HSA-9632974 | 2.696570e-01 | 0.569 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake | R-HSA-9031525 | 2.696570e-01 | 0.569 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 2.696570e-01 | 0.569 | 0 | 0 |
| STAT6-mediated induction of chemokines | R-HSA-3249367 | 3.979638e-01 | 0.400 | 0 | 0 |
| The NLRP1 inflammasome | R-HSA-844455 | 3.979638e-01 | 0.400 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 3.979638e-01 | 0.400 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of other transcription factors | R-HSA-8866906 | 3.979638e-01 | 0.400 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 3.979638e-01 | 0.400 | 0 | 0 |
| Signaling by plasma membrane FGFR1 fusions | R-HSA-8853336 | 3.979638e-01 | 0.400 | 0 | 0 |
| Defective SLC7A7 causes lysinuric protein intolerance (LPI) | R-HSA-5660862 | 3.979638e-01 | 0.400 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 3.069086e-01 | 0.513 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 3.069086e-01 | 0.513 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 3.069086e-01 | 0.513 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 2.286031e-01 | 0.641 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 2.286031e-01 | 0.641 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 2.286031e-01 | 0.641 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 3.437757e-01 | 0.464 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 3.437757e-01 | 0.464 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 3.437757e-01 | 0.464 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 4.560751e-01 | 0.341 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 4.560751e-01 | 0.341 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 4.560751e-01 | 0.341 | 0 | 0 |
| FBXW7 Mutants and NOTCH1 in Cancer | R-HSA-2644605 | 4.560751e-01 | 0.341 | 0 | 0 |
| Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling | R-HSA-2644607 | 4.560751e-01 | 0.341 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 4.560751e-01 | 0.341 | 0 | 0 |
| Defective FMO3 causes TMAU | R-HSA-5579019 | 4.560751e-01 | 0.341 | 0 | 0 |
| Signaling by LRP5 mutants | R-HSA-5339717 | 4.560751e-01 | 0.341 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 3.038225e-01 | 0.517 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 3.038225e-01 | 0.517 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 3.799858e-01 | 0.420 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 3.799858e-01 | 0.420 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 3.799858e-01 | 0.420 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 2.461827e-01 | 0.609 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 2.461827e-01 | 0.609 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 2.946388e-01 | 0.531 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 2.946388e-01 | 0.531 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 2.946388e-01 | 0.531 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 2.650479e-01 | 0.577 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 2.650479e-01 | 0.577 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 2.842227e-01 | 0.546 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 4.153224e-01 | 0.382 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 2.320296e-01 | 0.634 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 2.909366e-01 | 0.536 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 2.539539e-01 | 0.595 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 2.680269e-01 | 0.572 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 4.496170e-01 | 0.347 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 4.496170e-01 | 0.347 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 2.823171e-01 | 0.549 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 2.823171e-01 | 0.549 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 3.258705e-01 | 0.487 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 4.129804e-01 | 0.384 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 3.435513e-01 | 0.464 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 3.435513e-01 | 0.464 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 3.435513e-01 | 0.464 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 3.435513e-01 | 0.464 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 3.266128e-01 | 0.486 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 3.114512e-01 | 0.507 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 2.976975e-01 | 0.526 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 2.734577e-01 | 0.563 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 3.262458e-01 | 0.486 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 3.826771e-01 | 0.417 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 2.850963e-01 | 0.545 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 4.304449e-01 | 0.366 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 3.367479e-01 | 0.473 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 4.418588e-01 | 0.355 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 4.501713e-01 | 0.347 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 4.501713e-01 | 0.347 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 3.471213e-01 | 0.460 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 4.106925e-01 | 0.386 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 3.006561e-01 | 0.522 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 2.850952e-01 | 0.545 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 2.850952e-01 | 0.545 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 3.251793e-01 | 0.488 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 3.046167e-01 | 0.516 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 3.613206e-01 | 0.442 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 3.799858e-01 | 0.420 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 2.722836e-01 | 0.565 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 3.672072e-01 | 0.435 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 2.301944e-01 | 0.638 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 3.437757e-01 | 0.464 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 2.842227e-01 | 0.546 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 3.080969e-01 | 0.511 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 3.437757e-01 | 0.464 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 4.024956e-01 | 0.395 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 3.006561e-01 | 0.522 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 4.297097e-01 | 0.367 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 2.947523e-01 | 0.531 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 2.841774e-01 | 0.546 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 3.628307e-01 | 0.440 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 4.097291e-01 | 0.388 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 2.493572e-01 | 0.603 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 3.069086e-01 | 0.513 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 2.617345e-01 | 0.582 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 3.712451e-01 | 0.430 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 3.312953e-01 | 0.480 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 2.388231e-01 | 0.622 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 3.437757e-01 | 0.464 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 3.799858e-01 | 0.420 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 4.153224e-01 | 0.382 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 4.496170e-01 | 0.347 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 2.946388e-01 | 0.531 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 2.696570e-01 | 0.569 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 3.069086e-01 | 0.513 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 4.560751e-01 | 0.341 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 3.038225e-01 | 0.517 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 4.304449e-01 | 0.366 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 4.418588e-01 | 0.355 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 3.720975e-01 | 0.429 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 3.172127e-01 | 0.499 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 2.850952e-01 | 0.545 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 2.346561e-01 | 0.630 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 2.539539e-01 | 0.595 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 3.915785e-01 | 0.407 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 3.955323e-01 | 0.403 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 3.312953e-01 | 0.480 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 3.312953e-01 | 0.480 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 4.496170e-01 | 0.347 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 3.853880e-01 | 0.414 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 2.976975e-01 | 0.526 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 3.969694e-01 | 0.401 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 2.573180e-01 | 0.590 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 4.032802e-01 | 0.394 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 4.304449e-01 | 0.366 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 3.038225e-01 | 0.517 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 3.437757e-01 | 0.464 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 4.560751e-01 | 0.341 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 4.560751e-01 | 0.341 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 4.560751e-01 | 0.341 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 2.401222e-01 | 0.620 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 3.859975e-01 | 0.413 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by WNT ligand antagonists | R-HSA-3772470 | 4.496170e-01 | 0.347 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 4.024956e-01 | 0.395 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 3.934822e-01 | 0.405 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 4.222380e-01 | 0.374 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 4.326592e-01 | 0.364 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 3.949575e-01 | 0.403 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 2.835448e-01 | 0.547 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 3.232611e-01 | 0.490 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 3.613206e-01 | 0.442 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 4.097291e-01 | 0.388 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 3.868148e-01 | 0.412 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 4.317937e-01 | 0.365 | 0 | 0 |
| Inhibition of Host mRNA Processing and RNA Silencing | R-HSA-168315 | 2.624664e-01 | 0.581 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 3.336482e-01 | 0.477 | 0 | 0 |
| Influenza Virus Induced Apoptosis | R-HSA-168277 | 3.336482e-01 | 0.477 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 3.336482e-01 | 0.477 | 0 | 0 |
| Adenosine P1 receptors | R-HSA-417973 | 3.979638e-01 | 0.400 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 3.979638e-01 | 0.400 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 3.979638e-01 | 0.400 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 4.560751e-01 | 0.341 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 3.038225e-01 | 0.517 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 2.722836e-01 | 0.565 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 3.799858e-01 | 0.420 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 3.312953e-01 | 0.480 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 3.312953e-01 | 0.480 | 0 | 0 |
| Regulation of gene expression in early pancreatic precursor cells | R-HSA-210747 | 4.153224e-01 | 0.382 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 4.153224e-01 | 0.382 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 3.859975e-01 | 0.413 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 3.262458e-01 | 0.486 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 3.826771e-01 | 0.417 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 3.204823e-01 | 0.494 | 0 | 0 |
| S Phase | R-HSA-69242 | 2.502357e-01 | 0.602 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 3.653866e-01 | 0.437 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 2.396013e-01 | 0.621 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 4.135551e-01 | 0.383 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 3.861306e-01 | 0.413 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 2.408326e-01 | 0.618 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 4.372813e-01 | 0.359 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 3.437757e-01 | 0.464 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 3.430076e-01 | 0.465 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 3.799858e-01 | 0.420 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 3.799858e-01 | 0.420 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 3.399171e-01 | 0.469 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 2.636384e-01 | 0.579 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 3.853880e-01 | 0.414 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 3.628307e-01 | 0.440 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 3.768175e-01 | 0.424 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 2.764569e-01 | 0.558 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 3.038225e-01 | 0.517 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 4.380985e-01 | 0.358 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 3.292624e-01 | 0.482 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 4.080027e-01 | 0.389 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 4.304449e-01 | 0.366 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 3.425824e-01 | 0.465 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 2.624664e-01 | 0.581 | 0 | 0 |
| DSCAM interactions | R-HSA-376172 | 3.336482e-01 | 0.477 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 4.560751e-01 | 0.341 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 4.560751e-01 | 0.341 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 3.038225e-01 | 0.517 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 3.859975e-01 | 0.413 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 3.626684e-01 | 0.440 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 3.977372e-01 | 0.400 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 3.514077e-01 | 0.454 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 4.210118e-01 | 0.376 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 2.323590e-01 | 0.634 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 4.153224e-01 | 0.382 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 3.036469e-01 | 0.518 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 2.479655e-01 | 0.606 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 2.428010e-01 | 0.615 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 2.696570e-01 | 0.569 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 4.560751e-01 | 0.341 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 4.129804e-01 | 0.384 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 3.898865e-01 | 0.409 | 0 | 0 |
| Prostanoid ligand receptors | R-HSA-391908 | 4.153224e-01 | 0.382 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 3.859975e-01 | 0.413 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 4.559243e-01 | 0.341 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 4.496170e-01 | 0.347 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 3.069086e-01 | 0.513 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 3.437757e-01 | 0.464 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 3.859975e-01 | 0.413 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 3.218195e-01 | 0.492 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 4.129804e-01 | 0.384 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 2.946388e-01 | 0.531 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 3.853880e-01 | 0.414 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 3.799858e-01 | 0.420 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 3.678911e-01 | 0.434 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 3.547617e-01 | 0.450 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 2.402317e-01 | 0.619 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 4.568185e-01 | 0.340 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 4.656961e-01 | 0.332 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 4.656961e-01 | 0.332 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 4.675224e-01 | 0.330 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 4.676985e-01 | 0.330 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 4.676985e-01 | 0.330 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 4.745694e-01 | 0.324 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 4.757588e-01 | 0.323 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 4.805686e-01 | 0.318 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 4.827415e-01 | 0.316 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 4.827415e-01 | 0.316 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 4.827415e-01 | 0.316 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 4.827415e-01 | 0.316 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 4.827415e-01 | 0.316 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 4.827415e-01 | 0.316 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 4.827415e-01 | 0.316 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 4.827415e-01 | 0.316 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 4.827415e-01 | 0.316 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 4.827415e-01 | 0.316 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 4.827415e-01 | 0.316 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 4.857303e-01 | 0.314 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 4.886717e-01 | 0.311 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 4.895059e-01 | 0.310 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 4.912623e-01 | 0.309 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 4.961444e-01 | 0.304 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 4.961444e-01 | 0.304 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 4.965222e-01 | 0.304 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 4.992267e-01 | 0.302 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 5.056364e-01 | 0.296 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 5.077020e-01 | 0.294 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 5.085804e-01 | 0.294 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 5.085804e-01 | 0.294 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 5.085804e-01 | 0.294 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 5.085804e-01 | 0.294 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 5.085804e-01 | 0.294 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 5.085804e-01 | 0.294 | 0 | 0 |
| Defective F9 activation | R-HSA-9673221 | 5.085804e-01 | 0.294 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 5.085804e-01 | 0.294 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 5.085804e-01 | 0.294 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 5.085804e-01 | 0.294 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 5.085804e-01 | 0.294 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 5.085804e-01 | 0.294 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 5.085804e-01 | 0.294 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 5.085804e-01 | 0.294 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 5.085804e-01 | 0.294 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 5.089112e-01 | 0.293 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 5.146023e-01 | 0.289 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 5.146023e-01 | 0.289 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 5.146023e-01 | 0.289 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 5.146023e-01 | 0.289 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 5.146023e-01 | 0.289 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 5.146023e-01 | 0.289 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 5.162097e-01 | 0.287 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 5.173324e-01 | 0.286 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 5.173324e-01 | 0.286 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 5.183213e-01 | 0.285 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 5.183213e-01 | 0.285 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 5.183213e-01 | 0.285 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 5.183213e-01 | 0.285 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 5.192455e-01 | 0.285 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 5.217856e-01 | 0.283 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 5.353633e-01 | 0.271 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 5.353633e-01 | 0.271 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 5.355847e-01 | 0.271 | 0 | 0 |
| Kinesins | R-HSA-983189 | 5.355847e-01 | 0.271 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 5.355888e-01 | 0.271 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 5.367572e-01 | 0.270 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 5.367572e-01 | 0.270 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 5.380933e-01 | 0.269 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 5.380933e-01 | 0.269 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 5.384418e-01 | 0.269 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 5.404838e-01 | 0.267 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 5.404838e-01 | 0.267 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 5.451349e-01 | 0.263 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 5.451349e-01 | 0.263 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 5.451349e-01 | 0.263 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 5.496562e-01 | 0.260 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 5.524950e-01 | 0.258 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 5.548620e-01 | 0.256 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 5.560201e-01 | 0.255 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 5.560201e-01 | 0.255 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 5.560201e-01 | 0.255 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 5.560201e-01 | 0.255 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 5.560201e-01 | 0.255 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 5.560201e-01 | 0.255 | 0 | 0 |
| Defective CSF2RB causes SMDP5 | R-HSA-5688849 | 5.560201e-01 | 0.255 | 0 | 0 |
| Defective CSF2RA causes SMDP4 | R-HSA-5688890 | 5.560201e-01 | 0.255 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 5.560201e-01 | 0.255 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 5.560201e-01 | 0.255 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 5.560201e-01 | 0.255 | 0 | 0 |
| NGF-independant TRKA activation | R-HSA-187024 | 5.560201e-01 | 0.255 | 0 | 0 |
| Ceramide signalling | R-HSA-193681 | 5.560201e-01 | 0.255 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 5.560201e-01 | 0.255 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 5.560201e-01 | 0.255 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 5.560201e-01 | 0.255 | 0 | 0 |
| Relaxin receptors | R-HSA-444821 | 5.560201e-01 | 0.255 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 5.560201e-01 | 0.255 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 5.560201e-01 | 0.255 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 5.583923e-01 | 0.253 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 5.583923e-01 | 0.253 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 5.583923e-01 | 0.253 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 5.583923e-01 | 0.253 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 5.640403e-01 | 0.249 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 5.640403e-01 | 0.249 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 5.640403e-01 | 0.249 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 5.687195e-01 | 0.245 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 5.687195e-01 | 0.245 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 5.692607e-01 | 0.245 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 5.715956e-01 | 0.243 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 5.732456e-01 | 0.242 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 5.732460e-01 | 0.242 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 5.742987e-01 | 0.241 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 5.742987e-01 | 0.241 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 5.742987e-01 | 0.241 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 5.742987e-01 | 0.241 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 5.781993e-01 | 0.238 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 5.781993e-01 | 0.238 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 5.781993e-01 | 0.238 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 5.834216e-01 | 0.234 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 5.846523e-01 | 0.233 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 5.846523e-01 | 0.233 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 5.855547e-01 | 0.232 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 5.868438e-01 | 0.231 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 5.868438e-01 | 0.231 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 5.868438e-01 | 0.231 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 5.950434e-01 | 0.225 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 5.974890e-01 | 0.224 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 5.977279e-01 | 0.223 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 5.988827e-01 | 0.223 | 0 | 0 |
| Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells | R-HSA-210746 | 5.988827e-01 | 0.223 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 5.988827e-01 | 0.223 | 0 | 0 |
| Toxicity of botulinum toxin type F (botF) | R-HSA-5250981 | 5.988827e-01 | 0.223 | 0 | 0 |
| Toxicity of botulinum toxin type D (botD) | R-HSA-5250955 | 5.988827e-01 | 0.223 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 5.988827e-01 | 0.223 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 5.988827e-01 | 0.223 | 0 | 0 |
| CREB3 factors activate genes | R-HSA-8874211 | 5.988827e-01 | 0.223 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 6.020734e-01 | 0.220 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 6.020734e-01 | 0.220 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 6.020734e-01 | 0.220 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 6.020734e-01 | 0.220 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 6.020734e-01 | 0.220 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 6.034039e-01 | 0.219 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 6.041174e-01 | 0.219 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 6.069603e-01 | 0.217 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 6.088677e-01 | 0.215 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 6.088677e-01 | 0.215 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 6.095200e-01 | 0.215 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 6.162405e-01 | 0.210 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 6.162405e-01 | 0.210 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 6.162405e-01 | 0.210 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 6.214772e-01 | 0.207 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 6.235250e-01 | 0.205 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 6.235250e-01 | 0.205 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 6.235250e-01 | 0.205 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 6.235250e-01 | 0.205 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 6.235250e-01 | 0.205 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 6.235250e-01 | 0.205 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 6.284556e-01 | 0.202 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 6.284556e-01 | 0.202 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 6.284556e-01 | 0.202 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 6.284556e-01 | 0.202 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 6.284556e-01 | 0.202 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 6.284556e-01 | 0.202 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 6.300928e-01 | 0.201 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 6.300928e-01 | 0.201 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 6.300928e-01 | 0.201 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 6.324230e-01 | 0.199 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 6.326044e-01 | 0.199 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 6.344370e-01 | 0.198 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 6.344370e-01 | 0.198 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 6.376095e-01 | 0.195 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 6.376095e-01 | 0.195 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 6.376095e-01 | 0.195 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 6.376095e-01 | 0.195 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 6.376095e-01 | 0.195 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 6.376095e-01 | 0.195 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 6.376095e-01 | 0.195 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 6.376095e-01 | 0.195 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 6.376095e-01 | 0.195 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 6.376095e-01 | 0.195 | 0 | 0 |
| Activation of TRKA receptors | R-HSA-187015 | 6.376095e-01 | 0.195 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 6.376095e-01 | 0.195 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 6.376095e-01 | 0.195 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 6.379264e-01 | 0.195 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 6.451700e-01 | 0.190 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 6.461908e-01 | 0.190 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 6.466356e-01 | 0.189 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 6.498467e-01 | 0.187 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 6.505066e-01 | 0.187 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 6.505066e-01 | 0.187 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 6.505066e-01 | 0.187 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 6.507122e-01 | 0.187 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 6.520653e-01 | 0.186 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 6.520653e-01 | 0.186 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 6.534550e-01 | 0.185 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 6.534550e-01 | 0.185 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 6.553673e-01 | 0.184 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 6.608215e-01 | 0.180 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 6.701028e-01 | 0.174 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 6.701028e-01 | 0.174 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 6.706247e-01 | 0.174 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 6.725995e-01 | 0.172 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | R-HSA-8939242 | 6.725995e-01 | 0.172 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 6.725995e-01 | 0.172 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 6.725995e-01 | 0.172 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 6.725995e-01 | 0.172 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 6.725995e-01 | 0.172 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 6.725995e-01 | 0.172 | 0 | 0 |
| Calcitonin-like ligand receptors | R-HSA-419812 | 6.725995e-01 | 0.172 | 0 | 0 |
| RSK activation | R-HSA-444257 | 6.725995e-01 | 0.172 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 6.730072e-01 | 0.172 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 6.766889e-01 | 0.170 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 6.770928e-01 | 0.169 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 6.770928e-01 | 0.169 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 6.770928e-01 | 0.169 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 6.770928e-01 | 0.169 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 6.881825e-01 | 0.162 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 6.888807e-01 | 0.162 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 6.888807e-01 | 0.162 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 6.888807e-01 | 0.162 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 6.900153e-01 | 0.161 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 6.913459e-01 | 0.160 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 6.993988e-01 | 0.155 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 6.993988e-01 | 0.155 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 6.993988e-01 | 0.155 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 6.993988e-01 | 0.155 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 6.993988e-01 | 0.155 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 6.993988e-01 | 0.155 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 7.014190e-01 | 0.154 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 7.014637e-01 | 0.154 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 7.034821e-01 | 0.153 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 7.037459e-01 | 0.153 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 7.042129e-01 | 0.152 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 7.042129e-01 | 0.152 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 7.042129e-01 | 0.152 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 7.042129e-01 | 0.152 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 7.042129e-01 | 0.152 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 7.042129e-01 | 0.152 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 7.042129e-01 | 0.152 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 7.042129e-01 | 0.152 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 7.042129e-01 | 0.152 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 7.042129e-01 | 0.152 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 7.042129e-01 | 0.152 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 7.042129e-01 | 0.152 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 7.042129e-01 | 0.152 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 7.068439e-01 | 0.151 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 7.133063e-01 | 0.147 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 7.164774e-01 | 0.145 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 7.167568e-01 | 0.145 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 7.167568e-01 | 0.145 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 7.167568e-01 | 0.145 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 7.204098e-01 | 0.142 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 7.240005e-01 | 0.140 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 7.240005e-01 | 0.140 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 7.240005e-01 | 0.140 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 7.252290e-01 | 0.140 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 7.252290e-01 | 0.140 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 7.270960e-01 | 0.138 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 7.284244e-01 | 0.138 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 7.314647e-01 | 0.136 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 7.314647e-01 | 0.136 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 7.314647e-01 | 0.136 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 7.314647e-01 | 0.136 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 7.314647e-01 | 0.136 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 7.327754e-01 | 0.135 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 7.327754e-01 | 0.135 | 0 | 0 |
| TET1,2,3 and TDG demethylate DNA | R-HSA-5221030 | 7.327754e-01 | 0.135 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 7.327754e-01 | 0.135 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 7.327754e-01 | 0.135 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 7.327754e-01 | 0.135 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 7.327754e-01 | 0.135 | 0 | 0 |
| Arachidonate production from DAG | R-HSA-426048 | 7.327754e-01 | 0.135 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 7.327754e-01 | 0.135 | 0 | 0 |
| Defective factor IX causes hemophilia B | R-HSA-9668250 | 7.327754e-01 | 0.135 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 7.327754e-01 | 0.135 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 7.327754e-01 | 0.135 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 7.327754e-01 | 0.135 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 7.327754e-01 | 0.135 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 7.340773e-01 | 0.134 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 7.400464e-01 | 0.131 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 7.401678e-01 | 0.131 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 7.401678e-01 | 0.131 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 7.401678e-01 | 0.131 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 7.401678e-01 | 0.131 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 7.401678e-01 | 0.131 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 7.403620e-01 | 0.131 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 7.403620e-01 | 0.131 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 7.455917e-01 | 0.127 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 7.455917e-01 | 0.127 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 7.470302e-01 | 0.127 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 7.525743e-01 | 0.123 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 7.559430e-01 | 0.122 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 7.559430e-01 | 0.122 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 7.559430e-01 | 0.122 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 7.585814e-01 | 0.120 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 7.585814e-01 | 0.120 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 7.585814e-01 | 0.120 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 7.585814e-01 | 0.120 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 7.585814e-01 | 0.120 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 7.585814e-01 | 0.120 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 7.585814e-01 | 0.120 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 7.585814e-01 | 0.120 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 7.585814e-01 | 0.120 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 7.585814e-01 | 0.120 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 7.587188e-01 | 0.120 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 7.591439e-01 | 0.120 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 7.591439e-01 | 0.120 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 7.591439e-01 | 0.120 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 7.646295e-01 | 0.117 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 7.678935e-01 | 0.115 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 7.707606e-01 | 0.113 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 7.707606e-01 | 0.113 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 7.710570e-01 | 0.113 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 7.721295e-01 | 0.112 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 7.721295e-01 | 0.112 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 7.721295e-01 | 0.112 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 7.758422e-01 | 0.110 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 7.761117e-01 | 0.110 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 7.761117e-01 | 0.110 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 7.761117e-01 | 0.110 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 7.762346e-01 | 0.110 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 7.762346e-01 | 0.110 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 7.818966e-01 | 0.107 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 7.818966e-01 | 0.107 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 7.818966e-01 | 0.107 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 7.818966e-01 | 0.107 | 0 | 0 |
| FMO oxidises nucleophiles | R-HSA-217271 | 7.818966e-01 | 0.107 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 7.818966e-01 | 0.107 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 7.818966e-01 | 0.107 | 0 | 0 |
| Anchoring fibril formation | R-HSA-2214320 | 7.818966e-01 | 0.107 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 7.845580e-01 | 0.105 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 7.847024e-01 | 0.105 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 7.848339e-01 | 0.105 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 7.848339e-01 | 0.105 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 7.848339e-01 | 0.105 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 7.848339e-01 | 0.105 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 7.848339e-01 | 0.105 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 7.923970e-01 | 0.101 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 7.923970e-01 | 0.101 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 7.923970e-01 | 0.101 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 7.981178e-01 | 0.098 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 7.981841e-01 | 0.098 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 7.981841e-01 | 0.098 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 8.015027e-01 | 0.096 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 8.029614e-01 | 0.095 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 8.029614e-01 | 0.095 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 8.029614e-01 | 0.095 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 8.029614e-01 | 0.095 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 8.029614e-01 | 0.095 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 8.029614e-01 | 0.095 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 8.029614e-01 | 0.095 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 8.029614e-01 | 0.095 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 8.029614e-01 | 0.095 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 8.029614e-01 | 0.095 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 8.029614e-01 | 0.095 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 8.029614e-01 | 0.095 | 0 | 0 |
| Diseases associated with surfactant metabolism | R-HSA-5687613 | 8.029614e-01 | 0.095 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 8.029614e-01 | 0.095 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 8.076265e-01 | 0.093 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 8.076265e-01 | 0.093 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 8.076265e-01 | 0.093 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 8.077545e-01 | 0.093 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 8.077883e-01 | 0.093 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 8.108335e-01 | 0.091 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 8.108335e-01 | 0.091 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 8.108335e-01 | 0.091 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 8.199927e-01 | 0.086 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 8.218520e-01 | 0.085 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 8.218520e-01 | 0.085 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 8.218520e-01 | 0.085 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 8.218520e-01 | 0.085 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 8.219928e-01 | 0.085 | 0 | 0 |
| PDH complex synthesizes acetyl-CoA from PYR | R-HSA-9861559 | 8.219928e-01 | 0.085 | 0 | 0 |
| Chylomicron remodeling | R-HSA-8963901 | 8.219928e-01 | 0.085 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 8.219928e-01 | 0.085 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 8.219928e-01 | 0.085 | 0 | 0 |
| rRNA modification in the mitochondrion | R-HSA-6793080 | 8.219928e-01 | 0.085 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 8.219928e-01 | 0.085 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 8.219928e-01 | 0.085 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 8.219928e-01 | 0.085 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 8.228056e-01 | 0.085 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 8.228056e-01 | 0.085 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 8.228056e-01 | 0.085 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 8.277371e-01 | 0.082 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 8.281819e-01 | 0.082 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 8.287130e-01 | 0.082 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 8.309483e-01 | 0.080 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 8.341245e-01 | 0.079 | 0 | 0 |
| Depurination | R-HSA-73927 | 8.341245e-01 | 0.079 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 8.341245e-01 | 0.079 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 8.351255e-01 | 0.078 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 8.351255e-01 | 0.078 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 8.351255e-01 | 0.078 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 8.351255e-01 | 0.078 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 8.351255e-01 | 0.078 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 8.356219e-01 | 0.078 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 8.367905e-01 | 0.077 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 8.387404e-01 | 0.076 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 8.387404e-01 | 0.076 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 8.387609e-01 | 0.076 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 8.391871e-01 | 0.076 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 8.391871e-01 | 0.076 | 0 | 0 |
| Glycerophospholipid catabolism | R-HSA-6814848 | 8.391871e-01 | 0.076 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 8.391871e-01 | 0.076 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 8.391871e-01 | 0.076 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 8.442010e-01 | 0.074 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 8.448150e-01 | 0.073 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 8.448150e-01 | 0.073 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 8.474980e-01 | 0.072 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 8.474980e-01 | 0.072 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 8.474980e-01 | 0.072 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 8.474980e-01 | 0.072 | 0 | 0 |
| Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane | R-HSA-83936 | 8.474980e-01 | 0.072 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 8.481095e-01 | 0.072 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 8.482373e-01 | 0.071 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 8.514931e-01 | 0.070 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 8.537265e-01 | 0.069 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 8.547214e-01 | 0.068 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 8.547214e-01 | 0.068 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 8.547214e-01 | 0.068 | 0 | 0 |
| FASTK family proteins regulate processing and stability of mitochondrial RNAs | R-HSA-9837092 | 8.547214e-01 | 0.068 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 8.547214e-01 | 0.068 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 8.547214e-01 | 0.068 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 8.547214e-01 | 0.068 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 8.547214e-01 | 0.068 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 8.549022e-01 | 0.068 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 8.549022e-01 | 0.068 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 8.590198e-01 | 0.066 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 8.590198e-01 | 0.066 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 8.590198e-01 | 0.066 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 8.590198e-01 | 0.066 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 8.590198e-01 | 0.066 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 8.601723e-01 | 0.065 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 8.616304e-01 | 0.065 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 8.644113e-01 | 0.063 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 8.644113e-01 | 0.063 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 8.670780e-01 | 0.062 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 8.687560e-01 | 0.061 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 8.687560e-01 | 0.061 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 8.687560e-01 | 0.061 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 8.687560e-01 | 0.061 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 8.687560e-01 | 0.061 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 8.687560e-01 | 0.061 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 8.687560e-01 | 0.061 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 8.697396e-01 | 0.061 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 8.697396e-01 | 0.061 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 8.697396e-01 | 0.061 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 8.733674e-01 | 0.059 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 8.733674e-01 | 0.059 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 8.733674e-01 | 0.059 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 8.734429e-01 | 0.059 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 8.734856e-01 | 0.059 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 8.784162e-01 | 0.056 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 8.797049e-01 | 0.056 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 8.797049e-01 | 0.056 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 8.805071e-01 | 0.055 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 8.805071e-01 | 0.055 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 8.806353e-01 | 0.055 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 8.810360e-01 | 0.055 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 8.814355e-01 | 0.055 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 8.814355e-01 | 0.055 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 8.814355e-01 | 0.055 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 8.814355e-01 | 0.055 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 8.814355e-01 | 0.055 | 0 | 0 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | R-HSA-9651496 | 8.814355e-01 | 0.055 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 8.817954e-01 | 0.055 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 8.817954e-01 | 0.055 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 8.835165e-01 | 0.054 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 8.844812e-01 | 0.053 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 8.868464e-01 | 0.052 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 8.882299e-01 | 0.051 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 8.889613e-01 | 0.051 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 8.889613e-01 | 0.051 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 8.897200e-01 | 0.051 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 8.897200e-01 | 0.051 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 8.928907e-01 | 0.049 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 8.928907e-01 | 0.049 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 8.928907e-01 | 0.049 | 0 | 0 |
| Catecholamine biosynthesis | R-HSA-209905 | 8.928907e-01 | 0.049 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 8.928907e-01 | 0.049 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 8.950406e-01 | 0.048 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 8.951858e-01 | 0.048 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 8.958543e-01 | 0.048 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 8.971653e-01 | 0.047 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 8.971653e-01 | 0.047 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 8.971653e-01 | 0.047 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 8.971653e-01 | 0.047 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.006425e-01 | 0.045 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 9.009989e-01 | 0.045 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 9.032398e-01 | 0.044 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 9.032398e-01 | 0.044 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 9.032398e-01 | 0.044 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 9.032398e-01 | 0.044 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 9.032398e-01 | 0.044 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 9.032398e-01 | 0.044 | 0 | 0 |
| PKA activation | R-HSA-163615 | 9.032398e-01 | 0.044 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 9.032398e-01 | 0.044 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 9.032398e-01 | 0.044 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 9.032398e-01 | 0.044 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.034269e-01 | 0.044 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 9.041549e-01 | 0.044 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 9.041549e-01 | 0.044 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 9.051828e-01 | 0.043 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 9.055214e-01 | 0.043 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 9.055384e-01 | 0.043 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.075750e-01 | 0.042 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 9.107121e-01 | 0.041 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 9.107121e-01 | 0.041 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 9.107121e-01 | 0.041 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 9.107121e-01 | 0.041 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 9.107121e-01 | 0.041 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 9.125894e-01 | 0.040 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 9.125894e-01 | 0.040 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 9.125894e-01 | 0.040 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 9.125894e-01 | 0.040 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 9.125894e-01 | 0.040 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 9.125894e-01 | 0.040 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 9.125894e-01 | 0.040 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 9.125894e-01 | 0.040 | 0 | 0 |
| Crosslinking of collagen fibrils | R-HSA-2243919 | 9.125894e-01 | 0.040 | 0 | 0 |
| HDL remodeling | R-HSA-8964058 | 9.125894e-01 | 0.040 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 9.133295e-01 | 0.039 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 9.157715e-01 | 0.038 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 9.160439e-01 | 0.038 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 9.168592e-01 | 0.038 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 9.178494e-01 | 0.037 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 9.178494e-01 | 0.037 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 9.181013e-01 | 0.037 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.187145e-01 | 0.037 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.187622e-01 | 0.037 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 9.197485e-01 | 0.036 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 9.197485e-01 | 0.036 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.197485e-01 | 0.036 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 9.210362e-01 | 0.036 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 9.210362e-01 | 0.036 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 9.210362e-01 | 0.036 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 9.210362e-01 | 0.036 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 9.210362e-01 | 0.036 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 9.210362e-01 | 0.036 | 0 | 0 |
| Melanin biosynthesis | R-HSA-5662702 | 9.210362e-01 | 0.036 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 9.230790e-01 | 0.035 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 9.238879e-01 | 0.034 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 9.245201e-01 | 0.034 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 9.260814e-01 | 0.033 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.280092e-01 | 0.032 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 9.286672e-01 | 0.032 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 9.286672e-01 | 0.032 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 9.286672e-01 | 0.032 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 9.286672e-01 | 0.032 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 9.286672e-01 | 0.032 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 9.286672e-01 | 0.032 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 9.319403e-01 | 0.031 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 9.319403e-01 | 0.031 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.319403e-01 | 0.031 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 9.319403e-01 | 0.031 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 9.319403e-01 | 0.031 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 9.332751e-01 | 0.030 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 9.355611e-01 | 0.029 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 9.355611e-01 | 0.029 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 9.355611e-01 | 0.029 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 9.355611e-01 | 0.029 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 9.355611e-01 | 0.029 | 0 | 0 |
| Metabolism of Angiotensinogen to Angiotensins | R-HSA-2022377 | 9.355611e-01 | 0.029 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 9.355611e-01 | 0.029 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.373576e-01 | 0.028 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.373576e-01 | 0.028 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.373576e-01 | 0.028 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 9.403297e-01 | 0.027 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.403433e-01 | 0.027 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 9.417891e-01 | 0.026 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 9.417891e-01 | 0.026 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 9.417891e-01 | 0.026 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 9.417891e-01 | 0.026 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 9.417891e-01 | 0.026 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 9.417891e-01 | 0.026 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 9.417891e-01 | 0.026 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 9.421775e-01 | 0.026 | 1 | 1 |
| Orc1 removal from chromatin | R-HSA-68949 | 9.421775e-01 | 0.026 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 9.421775e-01 | 0.026 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.423640e-01 | 0.026 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 9.425308e-01 | 0.026 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 9.430839e-01 | 0.025 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 9.446966e-01 | 0.025 | 0 | 0 |
| Protein folding | R-HSA-391251 | 9.455905e-01 | 0.024 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 9.462940e-01 | 0.024 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 9.469882e-01 | 0.024 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 9.469882e-01 | 0.024 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 9.474155e-01 | 0.023 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.474155e-01 | 0.023 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 9.474155e-01 | 0.023 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 9.474155e-01 | 0.023 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 9.474155e-01 | 0.023 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 9.501365e-01 | 0.022 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 9.512574e-01 | 0.022 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 9.513520e-01 | 0.022 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 9.516628e-01 | 0.022 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 9.517671e-01 | 0.021 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 9.524984e-01 | 0.021 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 9.524984e-01 | 0.021 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 9.524984e-01 | 0.021 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 9.524984e-01 | 0.021 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 9.551969e-01 | 0.020 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.551969e-01 | 0.020 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 9.554741e-01 | 0.020 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 9.570903e-01 | 0.019 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 9.570903e-01 | 0.019 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.570903e-01 | 0.019 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.570903e-01 | 0.019 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 9.570903e-01 | 0.019 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 9.570903e-01 | 0.019 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.570903e-01 | 0.019 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 9.572645e-01 | 0.019 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 9.575829e-01 | 0.019 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.588305e-01 | 0.018 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.590203e-01 | 0.018 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.601793e-01 | 0.018 | 0 | 0 |
| Attachment of bacteria to epithelial cells | R-HSA-9638630 | 9.612385e-01 | 0.017 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.612385e-01 | 0.017 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 9.612385e-01 | 0.017 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 9.613189e-01 | 0.017 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 9.621806e-01 | 0.017 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 9.649859e-01 | 0.015 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 9.649859e-01 | 0.015 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.649859e-01 | 0.015 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 9.681122e-01 | 0.014 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.681122e-01 | 0.014 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.682981e-01 | 0.014 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 9.683712e-01 | 0.014 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 9.683712e-01 | 0.014 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 9.683712e-01 | 0.014 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.706374e-01 | 0.013 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.706374e-01 | 0.013 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 9.706374e-01 | 0.013 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 9.707313e-01 | 0.013 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 9.714294e-01 | 0.013 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 9.714294e-01 | 0.013 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 9.714294e-01 | 0.013 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 9.714294e-01 | 0.013 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 9.720886e-01 | 0.012 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.726780e-01 | 0.012 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 9.728126e-01 | 0.012 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 9.731423e-01 | 0.012 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.731423e-01 | 0.012 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.731423e-01 | 0.012 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 9.741921e-01 | 0.011 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 9.741921e-01 | 0.011 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 9.741921e-01 | 0.011 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.741921e-01 | 0.011 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.741921e-01 | 0.011 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.745528e-01 | 0.011 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.753609e-01 | 0.011 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 9.754336e-01 | 0.011 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.758513e-01 | 0.011 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.758513e-01 | 0.011 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 9.766877e-01 | 0.010 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.766877e-01 | 0.010 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.770235e-01 | 0.010 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.770235e-01 | 0.010 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 9.774017e-01 | 0.010 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.774017e-01 | 0.010 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 9.779457e-01 | 0.010 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.785983e-01 | 0.009 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 9.792784e-01 | 0.009 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.800768e-01 | 0.009 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 9.809788e-01 | 0.008 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 9.809788e-01 | 0.008 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 9.809788e-01 | 0.008 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 9.810036e-01 | 0.008 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 9.815797e-01 | 0.008 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.815797e-01 | 0.008 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 9.828185e-01 | 0.008 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.828185e-01 | 0.008 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 9.828185e-01 | 0.008 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 9.844803e-01 | 0.007 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.844803e-01 | 0.007 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 9.844803e-01 | 0.007 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.844803e-01 | 0.007 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 9.852003e-01 | 0.006 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.853835e-01 | 0.006 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 9.859816e-01 | 0.006 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.862023e-01 | 0.006 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.865758e-01 | 0.006 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 9.867358e-01 | 0.006 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 9.870679e-01 | 0.006 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 9.873377e-01 | 0.006 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 9.873377e-01 | 0.006 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.873377e-01 | 0.006 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.885317e-01 | 0.005 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 9.885626e-01 | 0.005 | 0 | 0 |
| Ubiquinol biosynthesis | R-HSA-2142789 | 9.885626e-01 | 0.005 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.885626e-01 | 0.005 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.885626e-01 | 0.005 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 9.887743e-01 | 0.005 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.894396e-01 | 0.005 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.896692e-01 | 0.005 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.896692e-01 | 0.005 | 0 | 0 |
| Biofilm formation | R-HSA-9931953 | 9.896692e-01 | 0.005 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 9.902560e-01 | 0.004 | 1 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 9.902560e-01 | 0.004 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.906687e-01 | 0.004 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.906687e-01 | 0.004 | 0 | 0 |
| Diseases associated with N-glycosylation of proteins | R-HSA-3781860 | 9.906687e-01 | 0.004 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.915716e-01 | 0.004 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 9.915716e-01 | 0.004 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.921255e-01 | 0.003 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.921493e-01 | 0.003 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.923561e-01 | 0.003 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.931239e-01 | 0.003 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.932534e-01 | 0.003 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.934116e-01 | 0.003 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 9.934126e-01 | 0.003 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 9.934269e-01 | 0.003 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.937893e-01 | 0.003 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.937893e-01 | 0.003 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 9.937893e-01 | 0.003 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.937893e-01 | 0.003 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 9.939751e-01 | 0.003 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 9.942076e-01 | 0.003 | 0 | 0 |
| Pyrimidine catabolism | R-HSA-73621 | 9.943904e-01 | 0.002 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.946221e-01 | 0.002 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 9.949333e-01 | 0.002 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.949333e-01 | 0.002 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.953994e-01 | 0.002 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.954212e-01 | 0.002 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 9.954237e-01 | 0.002 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 9.956053e-01 | 0.002 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.956337e-01 | 0.002 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.957412e-01 | 0.002 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.958667e-01 | 0.002 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 9.959251e-01 | 0.002 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.960585e-01 | 0.002 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.961560e-01 | 0.002 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.962038e-01 | 0.002 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 9.966282e-01 | 0.001 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 9.966282e-01 | 0.001 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.966282e-01 | 0.001 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 9.966642e-01 | 0.001 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 9.968285e-01 | 0.001 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 9.968285e-01 | 0.001 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.970695e-01 | 0.001 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 9.970695e-01 | 0.001 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.971329e-01 | 0.001 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 9.973682e-01 | 0.001 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 9.975125e-01 | 0.001 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.975159e-01 | 0.001 | 0 | 0 |
| Cytosolic sulfonation of small molecules | R-HSA-156584 | 9.975159e-01 | 0.001 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 9.975965e-01 | 0.001 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.977201e-01 | 0.001 | 0 | 0 |
| Transport of vitamins, nucleosides, and related molecules | R-HSA-425397 | 9.977686e-01 | 0.001 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 9.978932e-01 | 0.001 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 9.980535e-01 | 0.001 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.981318e-01 | 0.001 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.981328e-01 | 0.001 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.982841e-01 | 0.001 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.983393e-01 | 0.001 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.983472e-01 | 0.001 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 9.984234e-01 | 0.001 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.984512e-01 | 0.001 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.985072e-01 | 0.001 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.985072e-01 | 0.001 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 9.985516e-01 | 0.001 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.986518e-01 | 0.001 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.986696e-01 | 0.001 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.987824e-01 | 0.001 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.988780e-01 | 0.000 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.988868e-01 | 0.000 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.989004e-01 | 0.000 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.989004e-01 | 0.000 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.989004e-01 | 0.000 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.990069e-01 | 0.000 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.990069e-01 | 0.000 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.990069e-01 | 0.000 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.990069e-01 | 0.000 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 9.990224e-01 | 0.000 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.991031e-01 | 0.000 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.991319e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.991866e-01 | 0.000 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.991900e-01 | 0.000 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 9.993292e-01 | 0.000 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.993394e-01 | 0.000 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 9.993394e-01 | 0.000 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.993394e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.994178e-01 | 0.000 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 9.994377e-01 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.994449e-01 | 0.000 | 1 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.995134e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.995134e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.995606e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.995964e-01 | 0.000 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.995964e-01 | 0.000 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.995964e-01 | 0.000 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.995967e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.996194e-01 | 0.000 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.996205e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.996442e-01 | 0.000 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 9.996466e-01 | 0.000 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.996557e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.996764e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.996764e-01 | 0.000 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.996764e-01 | 0.000 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.996837e-01 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.997293e-01 | 0.000 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 9.997567e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.997784e-01 | 0.000 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.998415e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.998569e-01 | 0.000 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.998677e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.998833e-01 | 0.000 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.998851e-01 | 0.000 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.998928e-01 | 0.000 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.998928e-01 | 0.000 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.999116e-01 | 0.000 | 1 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.999367e-01 | 0.000 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.999429e-01 | 0.000 | 0 | 0 |
| Classical antibody-mediated complement activation | R-HSA-173623 | 9.999484e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999508e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.999580e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.999721e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.999722e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.999761e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.999761e-01 | 0.000 | 0 | 0 |
| Scavenging of heme from plasma | R-HSA-2168880 | 9.999794e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.999799e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.999855e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.999858e-01 | 0.000 | 1 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 9.999915e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999934e-01 | 0.000 | 0 | 0 |
| Creation of C4 and C2 activators | R-HSA-166786 | 9.999940e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999940e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999940e-01 | 0.000 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.999954e-01 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.999963e-01 | 0.000 | 0 | 0 |
| Initial triggering of complement | R-HSA-166663 | 9.999976e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999977e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999983e-01 | 0.000 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.999983e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.999988e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999990e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.999993e-01 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.999995e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999996e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.999996e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999998e-01 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 9.999999e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 1.000000e+00 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 1.000000e+00 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 1 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 1.000000e+00 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | -0.000 | 0 | 0 |